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Background: Epidemiological research has shown that hallucinations and 
delusions, the classic symptoms of psychosis, are far more prevalent in the 
population than actual psychotic disorder. These symptoms are especially 
prevalent in childhood and adolescence. Longitudinal research has 
demonstrated that psychotic symptoms in adolescence increase risk for 
psychotic disorder in adulthood. There has been little research, however, on the 
immediate clinicopathological significance of psychotic symptoms in 
adolescence and on the prevalence of prodromal risk syndromes in the 
community.
Aims:
Aim 1 : To assess the prevalence of psychotic symptoms and the association of 
psychotic symptoms with age and with DSM-IV Axis-1 psychopathology 
Aim 2: To assess the relationship between psychotic symptoms and suicidal 
behaviour
Aim 3: To assess the neurocognitive profile of adolescents who report psychotic 
symptoms
Aim 4: To assess the prevalence of prodromal risk syndromes in the population 
and assess associations with non-psychotic psychopathology and global 
functioning
Method: Data from three population studies were used: Study 1 involved a 
school-based survey of 1,131 1 1  -to 13-year olds for psychotic symptoms,
S u m m a ry
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assessed using the Adolescent Psychotic Symptom Screener, and for 
emotional and behavioural symptoms of psychopathology, assessed using the 
Strengths and Difficulties Questionnaire. Studies 2 and 3 involved in-depth 
diagnostic interview assessments of psychotic symptoms and lifetime Axis-1 
disorders in two community samples of 11-to 15-year olds, involving 423 
adolescents in total. Psychotic symptoms, Axis-1 psychiatric disorders and 
suicidal behaviour were assessed using the Schedule for Affective Disorders 
and Schizophrenia (K-SADS). Global functioning was assessed using the 
Children’s Global Assessment Scale. Neurocognition was assessed using the 
Measurement and Treatment Research to Improve Cognition in Schizophrenia 
(MATRICS) consensus battery. Prodromal risk syndromes were assessed using 
the criteria of prodromal syndromes from the Structured Interview for Prodromal 
Syndromes.
Results:
A majority of community-based adolescents who reported psychotic symptoms 
had at least one lifetime diagnosable Axis-1 disorder on clinical interview: Study 
2, Odds ratio (OR)=3.57, 95% confidence interval (CI95)=1.87-6.84, p<0.001; 
Study 3: OR=11.94, CI95=3.14-45.41, p<0.01. Psychotic symptoms (i) were 
associated with a wide range of non-psychotic Axis-1 disorders, (ii) were 
reported more commonly by younger adolescents, (iii) were increasingly 
associated with psychopathology with age and (iv) indexed high risk for multiple 
co-occurring diagnoses.
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Psychotic symptoms were associated with a 10-fold increased risk for any 
suicidal behaviour (ideation, plans or acts) in both interview studies (Study 2, 
OR=10.2, 95%CI=3.3-32.3, P<0.001; Study 3, OR=10.5, 95% CI=3.1-35.2, 
P0.001). Among all adolescents with suicidal ideation, those who also reported 
psychotic symptoms had a nearly 2 0 -fold increased risk for suicide plans and 
suicide acts compared to adolescents with suicidal ideation who did not report 
psychotic symptoms (OR=19.6, 95% Cl=1.8-216.1).
In tests of neurocognition, adolescents with psychotic symptoms performed 
significantly more poorly on three processing speed tasks -  Trail Making Test-A 
(F=3.3, p<0.05), Trail Making Test-B (F=3.1, p<0.05) and digit symbol coding 
task (F=7.0, p<0.001) -  as well as on a non-verbal working memory (spatial 
span) task (F=3.2, p<0.05).
Up to 8 % of the sample met clinical criteria for a prodromal risk syndrome. The 
risk syndrome group had a higher prevalence of co-occurring non-psychotic 
Axis-1 psychiatric disorders (OR=4.77, CI95=1.81 -  12.52; p<0.01) and poorer 
global functioning (F=24.5, df=1, p<0.0001) compared to controls.
Conclusions: The majority of adolescents who report psychotic symptoms 
have at least one lifetime diagnosable Axis-1 disorder and demonstrate poorer 
neurocognitive performance than controls. Prodromal risk syndromes are 
relatively common in the community, which has implications for the proposed 
DSM-V diagnosis of Attenuated Psychosis Syndrome. Psychotic symptoms are 
important risk markers for severe multiple Axis-1 disorders and suicidal
17
behaviour and should be routinely assessed in child and adolescent psychiatric 
clinics.
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C h ap ter  1: In trod u ction  (P art 1)
Existing evidence on the relationship between 
psychotic disorder and psychotic symptoms in the 
community
1.1 Background
Hallucinations and delusions have, since the 19th Century, been regarded as 
the classic symptoms of psychosis. Recently, however, our ideas about 
hallucinations and delusions are being challenged by findings from 
epidemiology. Simply put, hallucinations and delusions are more common than 
we think (Polanczyk et al., 2010, van Os et a/., 2009, Wiles eta i, 2006, Yung et 
al., 2009a). Research in this area is often traced to John Strauss who, in 1969, 
questioned the view that the symptoms of patients with psychosis differed 
qualitatively from other psychiatric patients and argued that hallucinations and 
delusions, while dichotomously diagnosed as present or absent in clinical 
samples, are in fact part of a continuum of experience varying continuously 
along dimensions of, for example, conviction, preoccupation and implausibility 
(Strauss, 1969).
This argument returned to the fore at the start of the 21st Century. Van Os et al. 
argued that hallucinations and delusions existed as points on continua not just 
in clinical populations but also in the general population (van Os eta i, 2000). In 
a random community sample of more than 7,000 adults, they found that 17.5%
reported hallucinations and/or delusions. This, they argued, suggested that a 
psychosis phenotype extends beyond the clinical concept of schizophrenia and 
related disorders. In the absence of illness, psychotic symptoms are also 
referred to as psychotic experiences (PEs) or psychotic-like experiences (PLEs) 
and this population is said to express a ‘non-clinical psychosis phenotype’.
The Dunedin birth cohort study also demonstrated a high prevalence of 
psychotic symptoms in the general population, with 26% of adults reporting at 
least one hallucination or delusion at age 26. Importantly, this study also 
provided important longitudinal data which demonstrated that psychotic 
symptoms confer increased risk for later psychotic disorder (Poulton et al., 
2000). Children aged 11 who reported psychotic symptoms were at a 5- to 16- 
fold increased risk of schizophreniform disorder at age 26. This finding was 
replicated by researchers in an Australian sample, who showed that self- 
reported auditory hallucinations at age 14 years were associated with increased 
risk for psychotic disorder at age 21 (Welham et al., 2009). These findings have 
led to a swell of interest in studying psychotic symptoms as a means of 
understanding the roots or origins of psychosis. A wide range of risk factors for 
schizophrenia have now been investigated in individuals who report psychotic 
symptoms and some striking similarities have emerged between the non-clinical 
and clinical populations (see Table 1.1)
22
1.2 Psychotic symptoms: familiality and heritability
Hanssen and colleagues investigated psychotic symptoms among 257 
members of the general population and reported familial clustering of the 
symptoms, in line with findings in family and adoption studies in schizophrenia 
(Hanssen etal., 2006). Furthermore, Polanczyk and colleagues (2010) have 
shown familial covariation of psychotic symptoms with maternal schizophrenia- 
spectrum disorder, as well as with family psychiatric hospitalisations and family 
suicide attempts. Twin studies have also established that psychotic symptoms 
are heritable, with studies showing greater concordance for psychotic 
symptoms among monozygotic compared to dizygotic twins (Lataster et al., 
2009, Polanczyk etal., 2010).
1.3 Schizophrenia-related social risk factors
An elevated incidence of schizophrenia has been consistently demonstrated 
amongst migrant and ethnic minority groups, particularly African-Caribbeans in 
the UK (Boydell et al., 2001, Fearon et al., 2006). Johns and colleagues found a 
similar pattern among individuals who report psychotic symptoms, with persons 
of African-Caribbean descent 2.5 times more likely to admit to hallucinations 
than the white British population (Johns et al., 2002). Similarly, Laurens and 
colleagues found that psychotic symptoms were more commonly reported by 
British children of African-Caribbean ethnicity than by white British children 
(Laurens et al., 2008). While they did not find a significant association with 
migration status, a larger representative Australian study of more than 10,000 
people showed that migrants from non-English speaking backgrounds were
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more likely to report psychotic symptoms on interview (Scott et al., 2006). 
Further social risk factors for schizophrenia, including unemployment, lower 
socioeconomic background and being unwed or divorced, were also replicated 
in this large Australian sample. Similarly, a higher rate of urbanicity, one of the 
most frequently reported findings in schizophrenia (Kelly et al., 2010, 
Krabbendam and van Os, 2005, Pedersen and Mortensen, 2001) has also been 
demonstrated in association with psychotic symptoms (Scott eta i, 2006).
1.4 Schizophrenia-related adverse childhood experiences risk 
factors
In line with findings in schizophrenia (Bechdolf et al., 2010, Morgan and Fisher,
2007, Read et al., 2005), psychotic symptoms have been found to be more 
common in adolescents who have had traumatic experiences, including 
physical abuse and unwanted sexual experiences (Arseneault et al., 2011, 
Bartels-Velthuis etal., 2012, Janssen eta i, 2004, Lataster etai, 2006). 
Similarly, an association has been reported between peer victimisation and risk 
of psychotic symptoms, with higher rates of symptoms reported by victims of 
bullying (Campbell and Morrison, 2007, Mackie eta i, 2011, Schreier et al.,
2009), but also, conversely, by perpetrators of bullying (Nishida etai, 2008). 
Mothers of children with psychotic symptoms have also been demonstrated to 
show increased levels of negative expressed emotion, though no difference has 
been shown in terms of maternal warmth (Polanczyk et ai, 2010).
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1.5 Schizophrenia-related substance use risk factors
The well established relationship between psychotic disorder and cannabis use 
(Arseneault etal., 2002, Arseneault et al., 2004, Di Forti et al., 2009, Moore et 
at., 2007, Zammit etal., 2002) has been replicated in adolescents with 
psychotic symptoms (Cougnard etal., 2007, Harley et al., 2009, Kuepper etal., 
2011, Miettunen et al., 2008). Henquet and colleagues showed that the risk for 
psychotic symptoms among adolescents and young adults increased in a dose- 
response manner relative to the frequency of cannabis use over a four-year 
period (Henquet etal., 2005). Harley and colleagues demonstrated a synergistic 
interaction between cannabis use and traumatic childhood events, with 
exposure to both variables associated with a greater risk of psychotic symptoms 
than the summed risk that each variable accounted for individually (Harley et 
al., 2009). In addition to cannabis use, both alcohol dependence and tobacco 
use have also been shown to be more common among individuals who report 
psychotic symptoms (Johns et al., 2004, Wiles et al., 2006).
1.6 Schizophrenia-related obstetric and developmental deficits
Adverse prenatal and perinatal events, including maternal infection and 
obstetric complications, are well-documented in schizophrenia (Cannon et al., 
2002b, Clarke etal., 2006, Lewis and Murray, 1987, Owen et al., 1988, Wright 
et al., 1995). Similar findings have been reported for young people who report 
psychotic symptoms. In the ALSPAC longitudinal study, maternal infection and 
obstetric complications were both shown to significantly increase the risk of 
psychotic symptoms later in childhood (Zammit etal., 2009). Neuromotor
25
deficits have also been demonstrated among adolescents who report psychotic 
symptoms (Blanchard et al., 2010, Cannon etal., 2002a). Mittal and colleagues, 
for example, demonstrated that dyskinetic movements were more common in 
young people with psychotic symptoms compared to controls (Mittal etal.,
2011). Associations with advanced paternal age and with winter and spring 
births, however, have failed to be replicated in individuals with psychotic 
symptoms (Polanczyk etal., 2010, Zammit etal., 2008).
1.7 Schizophrenia-related deficits in IQ, cognition and language
Lower IQ scores have, as in schizophrenia (Zammit et al., 2004), been 
demonstrated in the non-clinical psychosis population (Cannon etal., 2002a, 
Horwood etal., 2008, Johns etal., 2004). To date, however, there have been 
few studies of cognition for the non-clinical phenotype. Deficits in receptive, 
though not expressive, language have been reported (Blanchard etal., 2010, 
Cannon etal., 2002a). Blanchard and colleagues have also demonstrated 
poorer performance by adolescents with psychotic symptoms on the Trail- 
making test part B, though deficits were not found in a number of other 
neurocognitive tasks implicated in schizophrenia. Poorer performance in tests of 
verbal fluency have also been shown in men who report psychotic symptoms 
(Krabbendam et al., 2005).
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Table 1.1: Aetiological and risk factor continuity between clinical and non-clinical 
psychosis phenotypes
C ategory R is k  fac to r Sch izophrenia 
(C lin ic a l phenotype)
Psychotic 
sym ptom s 
(N o n c lin i cal 
phenotype)
G enetics/ F a m ilia l + +
T ransm iss ion H eritab le + +
Socia l U rb a n ic ity + +
M ig ra tio n + +
E th n ic  m in o r ity + +
L o w  soc io -econom ic 
background
+ +
U nem p loyed + +
U n m a rrie d /D ivo rce d + +
A dverse
ch ildhoo d
experiences
T raum a tic  ch ildhoo d  
phys ica l o r sexual 
experiences
+ +
B u lly in g /
V ic tim is a tio n
+ +
Parental dom estic  
v io lence
+ +
M a te rna l expressed 
em otion : n e g a tiv ity
+ +
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M aterna l expressed 
em otion : w a rm th
+
Substance use Cannabis use + +
Tobacco use + +
A lc o h o l dependence + +
O bste tric  and
D eve lopm en ta l
d e fic its
O bste tric  com p lica tions + +
M ate rna l in fe c tio n + +
N e u ro m o to r d e fic its + +
W in te r/sp r in g  b ir th + -
Paternal age + -
C o g n itio n  and 
Language
V e rb a l f lu e n cy + +
R eceptive  language + +
E xpress ive  language + -
T ra il-M a k in g  Test B + +
In te llig e n ce IQ + +
+  P os itive  find ings  
- N ega tive  fin d in g s
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The past decade of research summarised above illustrates an important 
continuum between the clinical and non-clinical psychosis phenotypes in the 
general population. Psychotic symptoms have been shown to be familial, 
heritable, confer increased risk for schizophrenia-spectrum disorder and covary 
with maternal psychotic disorder. Furthermore, these symptoms have been 
found to share an extensive range of social, environmental, motor, cognitive, 
linguistic and intellectual risk factors with schizophrenia.
1.10 Implications
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C h a p ter  2: In tro d u ctio n  (Part 2):
Systematic review and meta-analysis o f population- 
based studies on the prevalence o f psychotic 
sym ptom s in children and adolescents
2.1 Introduction
A review of the general population prevalence of psychotic symptoms by van 
Os and colleagues up to 2007 reported a median prevalence of 5% (van Os et 
al., 2009). However, this meta-analysis was based primarily on adult studies. 
There has been no systematic review to date on the prevalence of psychotic 
symptoms specifically in childhood or adolescence. This issue was addressed 
in the current thesis by carrying out a systematic review and meta-analysis of 
studies reporting prevalence rates for psychotic symptoms in the general 
population among children and adolescents up to age 18.
2.2 Method
2.2.1 Search Strategy
A systematic review was conducted on all published literature on the prevalence 
of psychotic symptoms in children and adolescents. We searched through 
electronic databases PUBMED, OVID MEDLINE, PsychlNFO and EMBASE 
from their inception to June 2011 with the following search terms: young people, 
adolescents, teenagers, child / children, psychotic symptoms, psychosis, 
paranoia, delusions, hallucinations, grandiosity, unusual beliefs/ideations,
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positive and negative symptoms, prevalence and psychotic-like experiences. 
We searched using the format [(Young people OR adolescents OR teenagers 
OR child) AND (prevalence) AND (psychotic symptoms OR psychosis OR 
paranoia OR delusions OR hallucinations OR grandiosity OR unusual 
beliefs/ideations OR positive symptoms OR negative symptoms OR psychotic- 
like experiences)].We also searched references within papers to identify other 
possible studies.
2.2.3 Inclusion Criteria
Methods used to assess the prevalence of psychotic symptoms in studies to 
date include interviews and questionnaire surveys. The latter approach has 
involved a number of different questionnaires that have had a great deal of 
variance in terms of the number of questions asked (from 1 to 92 items). 
Furthermore, endorsement rates of more than 90% for ‘at least one psychotic 
symptom’ have been reported in questionnaire studies (Wigman et ai, 2011), 
raising concerns about the validity of these items. Questionnaires have largely 
been unvalidated against clinical interview in terms of sensitivity and specificity 
and the inclusion of questionnaire studies risks overestimating the true 
prevalence of psychotic symptoms in the population. We recently showed, 
however, that some items on self-report questionnaire perform well in terms of 
identifying individuals with genuine psychotic symptoms when compared with 
gold standard clinical interview, while others perform poorly (Kelleher et al.,
2011). In particular, we found that a question on auditory hallucinations -  “Have 
you ever heard voices or sounds that no one else can hear?” -  demonstrated
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very good sensitivity, specificity and positive and negative predictive value not 
just for auditory hallucinations but for psychotic symptoms in general. Laurens 
etal. have also recently demonstrated, using item response theory analysis in a 
large population sample of children, that the same auditory hallucinations 
question demonstrates the strongest psychometric properties for assessing the 
continuum of psychotic symptoms compared to other questions (Laurens etal., 
2011). For this reason, in addition to including psychotic symptom prevalence 
rates from interview studies, we included reports that used the same question 
as in our initial validation report (Kelleher et a!., 2011), or a question with a 
similar wording, in order to calculate a meta-analytic median prevalence of 
psychotic symptoms in studies of children and adolescents.
2.2.4 Exclusion Criteria
We excluded papers for the following reasons (a) did not report prevalence 
rates or data from which rates could be calculated, (b) did not report rates for 
individuals under 18 years or allow calculation of rates for this age group, (c) 
reported psychotic symptoms that were sleep related, substance use related or 
organic in origin only or (d) reported on clinical samples -  that is 
inpatient/outpatient or help-seeking groups.
2.2.5 Study selection and data extraction
Four individuals (Ian Kelleher, Dearbhla Connor, Nina Devlin and Michelle 
Harley) independently conducted the searches and examined all titles and
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abstracts and assessed the relevance and appropriateness of the studies for 
the question under review (see Figure 2.1). Full texts of potentially relevant 
papers were obtained. Where necessary, authors were contacted for further 
information. From each paper collected, two individuals (Ian Kelleher and Mary 
Clarke) extracted data on the age range of participants and the reported rates of 
psychotic symptoms. Where samples overlapped (e.g., publications on 
preliminary data), papers that reported on the largest overall sample size were 
used.
2.2.6 Data Analysis
Eligible studies were divided into two groups according to whether participants 
were aged 9 to 12 years (the child population) or aged 13 to 18 years (the 
adolescent population). Where studies cut across these age ranges, the mean 
age of participants was used to assign the study to the ‘childhood’ or the 
‘adolescence’ group. We adopted the approach advocated by Saha et al. and 
also used in a previous psychotic symptom meta-analysis conducted by van Os 
etal. to summarise rate data, reporting median prevalences for both age groups 
(Saha etal., 2008, van Os etal., 2009).
2.3 Results
Our literature search yielded 3,597 papers. Titles and, as necessary, abstracts 
were read to determine articles of interest to the research question, yielding 199 
papers. Of these, 26 (13%) had data on psychotic symptom prevalence in
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community samples of young people. Seven of these studies were excluded 
because they involved questionnaire surveys that did not contain a question of 
similar wording to the question chosen for the research protocol or because it 
was not possible to calculate the endorsement rate for such a question. A total 
of 19 studies met criteria for inclusion - 5 interview studies (Horwood et al.,
2008, Kelleher et al., 2008, Kelleher et al., In Press, Polanczyk et al., 2010, 
Poulton et al., 2000) and 14 self report questionnaire studies (Barragan et al., 
2011, De Loore et al., 2011, Dhossche et al., 2002, Kelleher et al., In Press, 
Kinoshita et al., 2011, Lataster et al., 2006, Laurens et al., 2011, Scott et al., 
2009a, Scott et al., 2009b, Wigman et al., 2011, Yoshizumi et al., 2004, Yung et 
al., 2009a) (see Table 2.1). Prevalence rates were extracted from each study. 
The median prevalence of psychotic symptoms was 17% for the child 
population (ages 9 to 12 years), and 7.5% for the adolescent population (ages 
13 to 18 years).
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Figure 2.1: Flow chart for studies included in meta-analysis
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Table 2.1: Summary table of the prevalence rates of psychotic symptoms in the 19 community studies included in the systematic 
review
C o u n t r y  o f  s t u d y S o u r c e A g e  ( Y  e a rs ) M e t h o d  o f  A s s e s s m e n t O b s e r v e d
P r e v a le n c e
S p a in B a r r a g a n  et a l., 2 0 1 1 1 2  t o  1 8 Q u e s t io n n a i r e 3 1 . 7 %
N e t h e r la n d s D e  L o o r e  et al., 2 0 1 1 1 3  t o  1 4 Q u e s t io n n a i r e 5 %
N e t h e r la n d s D h o s s c h e  et a l., 2 0 0 2 11 t o  1 8 Q u e s t io n n a i r e 4 . 7 %
U K H o r w o o d  et al., 2 0 0 8 1 2 I n t e r v i e w 1 3 . 7 %
I r e la n d K e l l e h e r  et a l., 2 0 0 8 1 3  t o  1 5 I n t e r v i e w 6 . 6 %
I r e la n d K e l l e h e r  et a l., I n  P re s s
( a ) 11 t o  1 3 I n t e r v i e w 2 2 . 6 %
I r e la n d ( b ) 11 t o  13 Q u e s t io n n a i r e 2 1 . 2 %
I r e la n d ( c ) 1 3  t o  1 6 Q u e s t io n n a i r e 7 . 1 %
J a p a n
_
K i n o s h i t a  et a l., 2 0 1 1 1 2  t o  1 8 Q u e s t io n n a i r e 9 . 6 %
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N e t h e r la n d s L a t a s t e r  et a l., 2 0 0 6 1 3  t o  1 4 Q u e s t io n n a i r e 7 %
U K L a u r e n s  et al., 2 0 1 1 9  t o  1 2 Q u e s t io n n a i r e 3 5 . 3 %
U K P o la n c z y k  et a l., 2 0 1 0 1 2 I n t e r v i e w 1 9 . 6 %
N e w  Z e a la n d P o u l t o n  et a l., 2 0 0 0 11 I n t e r v i e w 1 4 . 7 %
A u s t r a l i a S c o t t  et a l., 2 0 0 9 a 1 3  t o  1 7 Q u e s t io n n a i r e 7 . 5 %
A u s t r a l i a S c o t t  et al., 2 0 0 9 b 1 4 Q u e s t io n n a i r e 1 0 . 6 %
N e t h e r la n d s W i g m a n  et a l., 2 0 1 1
( a ) 1 2  t o  1 6 Q u e s t io n n a i r e 2 2 . 2 %
N e t h e r la n d s ( b ) 1 0  t o  1 2 Q u e s t io n n a i r e 9 %
J a p a n Y o s h i z u m i  et a l., 2 0 0 4 11 t o  1 2 Q u e s t io n n a i r e 9 . 2 %
A u s t r a l i a Y u n g  et al., 2 0 0 9 1 3  t o  1 7 Q u e s t io n n a i r e 2 7 . 9 %
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This is the first systematic review to report on the prevalence of psychotic 
symptoms specifically in children and adolescents. A median of 17% of the 
childhood sample (9 to 12 years) reported psychotic symptoms, and 7.5% of 
the adolescent sample (13 to 18 years) reported psychotic symptoms. This 
compares to a median prevalence of 5% reported by van Os and colleagues 
in a meta analysis of mainly adult studies of psychotic symptoms (van Os et 
al., 2009), which supports the idea that psychotic symptoms are more 
prevalent in childhood compared to adulthood. This is also in line with 
longitudinal research, which has shown a decline in the incidence of 
psychotic symptoms in young people followed over time (Bartels-Velthuis et 
al., 2011, De Loore etal., 2011, Dominguez et al., 2011, Laurens etai,
2011, Mackie et al., 2011).
This meta-analysis has a number of strengths: firstly, an ‘a priori’ design was 
used whereby the research question and inclusion criteria were formulated 
before the conduct of the review. Secondly, four independent researchers 
carried out the data searches and two independent researchers extracted the 
specific data. The use of a validated psychotic symptom assessment 
question used in all of the questionnaire studies helps us to control for quality 
of assessment across studies.
Hallucinations and delusions have typically been viewed as symptoms of 
psychosis and, in keeping with this, population research to date has largely
2.4 Discussion
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considered these symptoms to represent a distributed risk for psychosis in 
the population (Polanczyk eta!., 2010, van Os etal., 2009). However, the 
relatively high prevalence of these symptoms would suggest a lack of 
specificity in terms of risk for psychosis. A number of recent studies have 
suggested that psychotic symptoms may predict a wider range of 
psychopathology than adulthood psychosis. Varghese etal., for example, 
reported an increased prevalence of psychotic symptoms among individuals 
who screened positive for depressive and anxiety disorders on the 
Composite International Diagnostic Interview (Varghese etal., 2011). 
Furthermore, Rossler etal. have recently shown that psychotic symptoms at 
age 19 or 2 0  years predict a wide range of (non-psychotic) mental disorders 
in follow up studies 30 years later (Rossler et al, 2011).
Conclusion
Psychotic symptoms are common in childhood and adolescence, with a 
median of 17% of 9 to 12 year olds and 7.5% of 13 to 18 year olds reporting 
symptoms. While an increased risk for psychosis is well established for 
young people who report psychotic symptoms (Poulton et al., 2000, Welham 
et al., 2009), more recent research has suggested that these symptoms may 
be important in relation to a wide variety of non-psychotic psychopathology 
(Rossler etal., 2011, Varghese etal., 2011). Further work is necessary to 
test the relationship between psychotic symptoms and non-psychotic 
psychopathology.
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C h a p ter  3: A im s  o f  th is  w o rk
3.1 Psychotic symptoms and Axis-1 psychopathology
Aim 1: To assess the prevalence of psychotic symptoms and the association 
of psychotic symptoms with age and with Axis-1 psychopathology
While psychotic symptoms have typically been viewed as a marker of risk for 
psychotic disorder, more recently, several research groups have reported 
that individuals who report psychotic symptoms are also more likely to report 
symptoms of non-psychotic psychopathology, especially symptoms of 
depression (Nishida etal., 2008, Scott eta!., 2009b, Varghese etal., 2011). 
Yung et al., for example, reported that individuals who had a diagnosed 
depressive disorder endorsed an increased number of psychotic symptoms 
on the Community Assessment of Psychic Experiences (CAPE) 
questionnaire compared to controls (Yung etal., 2007a). Bartels-Velthuis et 
al. found that young adolescents who disclosed psychotic symptoms were 
approximately 3 to 5 times more likely to score in the clinical 
psychopathology range on the parent-completed Child Behaviour Checklist 
(Bartels-Velthuis et al., 2011). Community based studies to date, however, 
have relied mainly upon questionnaires to assess psychotic symptoms and 
have involved limited data on non-psychotic psychopathology. In addition, 
although the meta-analysis above suggests that psychotic symptoms are 
more common in younger compared to older children, there is a lack of 
information on whether there are differences in the clinical significance of 
psychotic symptoms across different stages of adolescence. In an attempt to
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improve our understanding of the clinical significance of psychotic symptoms 
in the general population, data from one large population survey and two in- 
depth clinical interview studies of psychotic symptoms were used in the 
current thesis. The aims of this work were (i) to investigate whether psychotic 
symptoms predicted non-psychotic clinical diagnoses and, if so, which 
disorders (ii) to investigate whether psychotic symptoms predicted more 
clinically severe disorder, in terms of having multiple diagnosable disorders 
and (iii) to investigate whether the significance of psychotic symptoms varied 
as a function of age.
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3.2 Psychotic symptoms and suicidal behaviour
Aim 2: To assess the relationship between psychotic symptoms and suicidal 
behaviour
Suicidal behaviour is one of the most important causes of mortality 
worldwide. According to WHO (2008) estimates, there are approximately 
one million deaths by suicide annually and reducing suicide is a national 
health priority for many countries, including Ireland. The causes of suicidal 
behaviour, however, remain poorly understood (Batty etal., 2010). An 
increased prevalence of suicidal behaviour in psychosis is well established.
In fact, when Eugen Bleuler first defined schizophrenia in 1911, he 
recognized the ‘suicidal drive’ as ‘the most serious of schizophrenic 
symptoms’ (Bleuler, 1911). Psychosis patients have recently been shown to 
be at a 1 2 -fold increased risk of completed suicide compared to the general 
population (Dutta etal., 2010). However, psychosis is only known to play a 
role in a small absolute number of cases of suicidal behaviour.
Recent evidence from both clinical and population research has pointed to 
psychotic symptoms as potentially important markers of risk for suicide. In an 
emergency psychiatry patient sample, Penagaluri et al. noted that patients 
who reported subclinical hallucinations had more severe suicidal ideation 
(Penagaluri etal., 2010). Similarly, following a review of medical records of 
patients with suicidal behaviour, which showed a high rate of hallucinations 
in particular in early adolescence, Hysinger et al. stressed the need for
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further research on the role of psychotic symptoms in suicidal behaviour 
(Hysinger et ai, 2011). In population-based research, two recent 
questionnaire surveys have linked psychotic symptoms and suicidal 
behaviour. Nishida et al. found that adolescents who endorsed a 
questionnaire item about hallucinations were 3-times more likely to also 
endorse an item related to suicidal ideation (Nishida et ai, 2010). Saha et al., 
on the other hand, found that individuals who endorsed questionnaire items 
about delusions were 2 to 4 times more likely to endorse questionnaire items 
on suicidal behaviour (Saha et al., 2011). There have been no 
epidemiological studies to date, however, that have reported data on 
psychotic symptoms and suicidality in individuals who have received a 
clinical assessment for suicidal behaviour.
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3.3 Psychotic symptoms and neurocognition
Aim 3: To assess the neurocognitive profile of adolescents who report 
psychotic symptoms
Neurocognitive impairments are among the most replicated findings in 
schizophrenia (Fioravanti et al., 2005). Deficits have been demonstrated 
across a wide range of cognitive domains (Heinrichs and Zakzanis, 1998). 
Recently, however, debate has emerged over the primacy of certain 
neurocognitive deficits over others. Addressing this question is crucial 
because neurocognitive deficits inform us about the pathophysiology of the 
underlying disease and, therein, provide important direction for research on 
treatment. The importance of this has been reflected in the recent 
galvanisation of efforts from government, industry and academia to produce 
a consensus cognitive battery for the purposes of research into treatment of 
psychosis -  the Measurement and Treatment Research to Improve Cognition 
in Schizophrenia (MATRICS) battery, developed under the aegis of the US 
National Institute of Mental Health (Kern et al., 2008, Nuechterlein et al.,
2008).
A number of researchers have recently argued that impairments in 
processing speed represent the core neurocognitive deficit of psychosis 
(Carrion etal., 2011, Dickinson, 2008, Dickinson etal., 2007, Rodriguez- 
Sanchez etal., 2007). Deficits in processing speed, that is, the speed with 
which cognitive operations can be performed, have not only been shown in
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patients with chronic schizophrenia (Dickinson etal., 2007) but have also 
been demonstrated in first episode psychosis (Mesholam-Gately etal., 2009) 
and in the psychosis prodrome (Seidman etal., 2010). In an attempt to test 
the primacy of processing speed deficits over other neurocognitive deficits in 
schizophrenia, Rodriguez-Sanchez et al. conducted a multivariate analysis of 
neurocognitive performance in a sample of early psychosis patients 
(Rodriguez-Sanchez et al., 2007). The authors demonstrated impairments 
across a wide variety of tests. However, they found that differences for all 
other cognitive domains were no longer significant once they adjusted for the 
effect of processing speed, supporting the centrality of this deficit to 
psychosis. Dickinson et al. argued that a particular type of processing speed 
task, digit symbol coding, taps into the impairment that is at the core of 
cognitive dysfunction in psychosis (Dickinson et al., 2007). In a meta­
analysis of 40 studies, they found that the effect size of the impairment on 
this task significantly exceeded the effect sizes of tasks commonly used to 
measure more specific cognitive domains, including episodic memory, 
executive function and working memory. In a subsequent meta-analysis, 
Knowles et al. reported that a number of variables moderated the effect size 
of symbol coding task deficits, most notably anti-psychotic medication 
(Knowles et al., 2010), thus raising questions about how intrinsic processing 
speed impairment is to the pathology itself as opposed to downstream 
factors associated with the illness. A solution to this methodological problem 
is to examine the association between neurocognition and psychosis in a 
population sample who have not yet had contact with mental health services 
and who, thus, have not been exposed to treatment effects, including
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antipsychotic medication. Young people with psychotic symptoms, while part 
of a psychosis continuum, are distal from psychotic illness and, thus, 
potential confounds such as disease chronicity and medication. This 
approach can, thus, facilitate investigation of the earliest cognitive risk 
factors underlying psychosis risk.
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3.4 Prodromal risk syndromes in the population
Aim 4: To assess the prevalence of prodromal risk syndromes in the 
population and assess associations with non-psychotic psychopathology and 
global functioning
The onset of psychosis is usually preceded by a prodromal period prior to 
full-blown illness. Intervention at this early stage offers the hope of disease 
prevention. The concept of prodromal intervention as currently conceived 
emerged from research at the University of Melbourne in the 1990s. Yung, 
McGorry and colleagues developed a set of ‘ultra high risk’ (UHR) criteria for 
help-seeking individuals who presented to the clinic, which they 
demonstrated could predict a very high transition rate to psychosis 
(approximately 40%) over a 12-month period. Individuals meeting UHR 
criteria are said to have an ‘at risk mental state’ (ARMS). These criteria were 
used to formulate the Comprehensive Assessment of At Risk Mental States 
(CAARMS), a clinical instrument for the assessment of ARMS based upon 
defined criteria involving (i) attenuated psychotic symptoms, (ii) frank 
psychotic symptoms of brief duration or (iii) genetic risk combined with 
functional deterioration (McGorry et al., 2002, Yung et a/., 1996, Yung et al., 
2003). Researchers at Yale University developed the Structured Interview for 
Prodromal Syndromes (SIPS) with a similar goal and demonstrated that, in 
line with Australian findings, individuals who met criteria for these ‘prodromal 
risk syndromes’ were at very high risk for psychosis (Addington et al., 2007, 
Cannon etal., 2008, McGlashan eta!., 2001). In Europe, a set of ‘basic
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symptoms’, such as problems in dividing attention, thought blockages and 
disturbances in receptive and expressive language, have been used to 
successfully predict high risk for psychosis, either alone or in combination 
with UHR criteria (Klosterkotter etal., 2005, Klosterkotter etal., 1997, 
Ruhrmann etal., 2010b, Salokangas etal., 2011). The largest study to date 
examining transition from prodromal risk syndrome to psychosis has been 
the collaborative North American Prodrome Longitudinal Study (NAPLS), 
which reported that up to 40% of individuals who met risk syndrome criteria 
converted to psychosis over 2.5 years (Cannon etai, 2008, Woods etal,
2009).
Such has been the impact of risk syndrome research that a new diagnosis -  
‘Attenuated Psychosis Syndrome’ -  has been proposed for the next version 
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) (see 
Table 4.1). The goal of a new diagnosis is to provide a diagnostic category 
that facilitates identification, treatment and research. This proposal, however, 
has sparked a great deal of debate amongst leading researchers in the field 
(Carpenter and van Os, 2011, Corcoran etal., 2010, Drake and Lewis, 2010, 
McGorry, 2010, Ruhrmann etal., 2010a, Woods etal., 2010, Yung etal.,
2010). One important issue is the lack of population studies -  while a great 
deal of research has been conducted on psychotic symptoms in the general 
population to date (Poulton etal., 2000, van Os etal., 2009, Yung etal., 
2009b), population researchers have not conducted the in-depth clinical 
assessments that have characterized the work of researchers at UHR clinics. 
On the other hand, UHR researchers have, to date, focused almost
48
exclusively on help-seeking (i.e., self-presenting) individuals, without 
venturing into the community. A more complete understanding of prodromal 
risk syndromes requires that the detailed work carried out in UHR clinics be 
combined with a community-based, epidemiological approach. One 
preliminary report that has begun to address this issue involved telephone 
SIPS interviews with a sample of 16 to 35 year olds from the general 
population (Schimmelmann et ai, 2011). The researchers reported that just 
one participant fulfilled criteria for a prodromal risk syndrome. However, this 
study was limited by the small sample size (n=58) and the lack of information 
on the validity of telephone interviews compared to face-to-face assessment. 
With this in mind, further aims of the present work were to (i) test whether 
prodromal risk syndromes/at risk mental states could be identified among 
young adolescents in the general population and (ii) characterize these 
individuals in terms of psychopathology and general functioning.
I
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C h a p ter  4: M e th o d o lo g y
4.1 Survey study: Associations between psychotic symptoms 
and psychopathology
4.1.1 Study 1: the Adolescent Brain Development (ABD) survey 
study
The ABD study was established to assess the prevalence and 
clinicopathological significance of psychotic symptoms in community-based 
adolescents. The survey study took place in a two-stage format. The study 
team visited schools and gave a short information session about brain 
development in childhood and adolescence to 5th and 6th classes (i.e., pupils 
in the two most senior classes, aged 11-13 years). Consent forms for the 
study were distributed for the children to take home to their parents. This was 
an ‘opt in’ study, with written parental consent required for adolescents to 
take part. On the form parents were asked to tick one box to indicate consent 
for their child to complete the questionnaire in the classroom. Parents were 
also asked to tick a second box and leave contact details if they would like to 
hear about the second stage of the study involving an interview and further 
testing. The study team returned to the school one week later to collect the 
completed forms and administer the questionnaire in the classrooms. The 
questionnaire took just a few minutes for each child to complete. They 
completed the questionnaires in the classrooms in small groups with the 
researcher present. For the sake of confidentiality, pupils were asked to 
complete the questionnaire without allowing anyone else to see their
50
answers, but could ask a researcher for clarification of any question that they 
did not understand.
Sixteen schools in Dublin, Ireland and surrounding areas, took part in this 
study. In total 2190 consent forms were distributed and 1131 (52%) parents 
gave signed consent for their child to complete the survey in school. A total 
of 88.9% of participants were Irish-born participants (compared to 90.3% of 0 
to 14 year olds nationally in the 2006 national census).
4.1.2 Exposure and Outcome measures
Using the Adolescent Psychotic Symptom Screener (APSS -  see Appendix 
for copy), we have previously shown that a question on auditory 
hallucinations (“Have you ever heard voices or sounds that no one else can 
hear?”) demonstrates very good positive and negative predictive validity not 
just for clinical interview-verifiable auditory hallucinations but for psychotic 
symptoms in general (Kelleher et a/., 2011). This question was used in both 
survey studies to assess for psychotic symptoms (exposure measure).
The Strengths and Difficulties Questionnaire (SDQ) was used as the 
measure of general psychopathology in both samples (Goodman eta!.,
2000) (see Appendix for copy). The SDQ is a well-validated brief screening 
instrument, which asks about 25 attributes divided into subscales. The 
emotional disorders section assesses for anxiety, depressive and obsessive 
compulsive disorders, the conduct disorders section assesses for conduct 
and oppositional defiant disorders, and the hyperkinetic disorders section
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assesses for attention deficit/hyperactivity disorders. A ‘total difficulties’ score 
is also generated by summing the psychopathology subscales, which 
predicts the presence of any psychiatric disorder. The SDQ has been 
validated both in terms of its ability to distinguish between clinic and 
community samples (Goodman, 1997) and as a screening device to detect 
children with a mental health disorder (Goodman etal., 2000). More recently, 
the SDQ has been shown not only to predict psychopathology at the same 
point in time but also to predict disorder status three years later (Goodman 
and Goodman, 2009).
4.1.3 Statistical Analyses for ABD survey study
Statistical analyses were conducted using STATA version 11.0 for Windows. 
First, analysis of variance was used to test the association between 
endorsement of the auditory hallucinations question and SDQ total difficulties 
score. Second, the samples were divided into quartiles based on their SDQ 
total difficulties scores and logistic regression was used to test the odds of 
reporting psychotic symptoms in each quartile of (Increasing) 
psychopathology. To test for a statistically significant increase (or decrease) 
in the prevalence of psychotic symptoms across the quartiles of SDQ-rated 
psychopathology, the STATA command nptrend was used, which is an 
extension of the Wilcoxon rank-sum test and performs a nonparametric test 
for trend across ordered groups. Logistic regression was also used to 
compare the prevalence of auditory hallucinations among the 5% who scored 
highest on the SDQ total difficulties, which is often taken as a ‘severe’ 
psychopathology group, with the 5% who scored lowest on the SDQ total
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difficulties. Finally, we stratified by the number of SDQ-rated disorder 
domains (emotional, conduct and hyperkinetic disorders) and used logistic 
regression to determine whether psychotic symptoms predicted comorbidity 
across these domains and, therein, more severe psychopathology.
4.2 Interview studies: Associations between psychotic 
symptoms, psychopathology and suicidal behaviour
4.2.1 Study 2: the Adolescent Brain Development interview study
Participants in the ABD clinical interview study were drawn from the larger 
survey study of 11 to 13 year olds reported above. Of the 1131 adolescents 
who took part in the survey study, 656 (58%) indicated an interest in taking 
part in the interview study and a sample of 212 of these attended for 
interview. Among the first 20% of the sample who attended for interview we 
enriched at a rate of 2:1 for adolescents with a score of 2 or more on the 
APSS psychotic symptoms questionnaire. For the majority (80%), however, 
the sample was a random sample representative of the overall larger 
surveyed sample. A frequency weight was applied in STATA for all statistical 
analyses to account for enrichment at a rate of 2:1 in the first 20% of 
interviewed participants.
In order to test whether the interview sample were representative of the total 
population, we compared our interview sample with national demographic 
statistics and with data from the larger survey sample. The SES of 
participants approximated national figures: 34.6% of participants were
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categorized as SES groups 1-2 (compared to 32.1% of the national 
population) and 65.4% as SES groups 3-7 (compared to 67.9% of the 
national population). Participants were also representative of the overall 
national ethnic profile from the 2006 national census, including 88.9% Irish- 
born participants (compared to 90.3% of 0 to 14 year olds nationally). 
Furthermore, adolescents who attended for interview were no more likely to 
have an abnormal or borderline-abnormal score on the SDQ (x2=1.22 (df=1) 
p=0.27) and did not differ significantly in their scores on the APSS compared 
to the non-intervlewed sample (interviewed group mean=1.8 (SE=0.12), non­
interviewed group mean=1.9 (SE=0.19); t=0.26, df=1130, p=0.79).
4.2.2 Study 3: the Challenging Times interview study
The Challenging Times (CT) study was established to investigate the 
prevalence of psychiatric disorders and suicidal behaviour among Irish 
adolescents aged 13 to 15 years. The study was carried out in the 
geographical catchment area of a Child and Adolescent Mental Health Team 
in North Dublin with a population of 137,000. The participating schools were 
selected using a stratified random sampling technique according to the 
approximate socioeconomic class of the school in order to approximate to 
the geographical area population. A total of 743 pupils in eight mainstream 
schools were screened for psychiatric symptoms using the SDQ (Goodman 
etal., 2000), and with the Children’s Depression Inventory (Kovacs, 1985), 
which assesses cognitive, affective and behavioural signs of depression. 
Written informed consent was obtained from the parent or guardian of 
participants. One hundred and forty adolescents scored above threshold on
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these instruments, indicating high risk of having mental health problems, and 
all of these adolescents were invited to interview, of whom 117 (83.6%) 
agreed to attend for full psychiatric interview. A comparison group of 173 
adolescents, matched for gender and school were also invited to attend, of 
whom 94 (54%) agreed. A frequency weight was applied to participants in 
the CT study to account for enrichment for psychopathology so that reported 
rates represent the general population rather than a psychopathology- 
enriched sample. Higher SES individuals were slightly over-represented in 
the CT study compared to the population norm, with 39.9% of participants 
categorized as SES groups 1-2 and 60.1% as SES groups 3-7. Data were 
not collected on participant nationalities.
4.2.3 Exposure and Outcome Measures -  Axis-1 
psychopathology
The interview instrument used in both studies was the Schedule for Affective 
Disorders and Schizophrenia for School-aged Children, Present and Lifetime 
versions (K-SADS-PL) (Kaufman et ai, 1996). The K-SADS is a well- 
validated semi-structured research diagnostic interview for the assessment 
of all Axis-1 psychiatric disorders in children and adolescents. Children and 
parents were interviewed separately, both answering the same questions 
about the child. In the early adolescence study, interviews were conducted 
by two psychiatrists and four psychologists and in the mid adolescence 
study, interviews were conducted by one psychiatrist and two psychologists, 
all trained in the use of the K-SADS. The Psychosis section of the K-SADS 
was used to assess the participants’ psychotic symptoms (hallucinations and
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delusions). All interviewers recorded extensive notes of potential psychotic 
phenomena in this section of the interview and a clinical consensus meeting 
was held following the interviews to classify these phenomena as psychotic 
symptoms (or not), blind to diagnoses and all other information on the 
participants. The exposure measure was the presence or absence of 
psychotic symptoms and the outcome measure was a DSM diagnosable 
lifetime affective, anxiety or behavioural disorder.
4.2.4 Statistical analyses
Statistical analyses were conducted using STATA version 11.0 for Windows. 
Univariate and multivariate regression analyses were used to measure the 
relationship between psychopathology and psychotic symptoms. First, the 
prevalence of psychotic symptoms is reported in diagnosable affective, 
behavioural and anxiety disorders, together with odds ratios and 95% 
confidence intervals. Second, I stratify by the presence of multiple 
psychopathology (that is, having 2 or more diagnosable Axis-1 diagnoses) in 
order to determine the prevalence of psychotic symptoms in increasingly 
severe (multiple) disorders and report odds ratios and 95% confidence 
intervals for the association with psychotic symptoms. To test for a 
statistically significant increase (or decrease) in the prevalence of auditory 
hallucinations in line with the number of diagnosable Axis-1 disorders, the 
STATA command nptrend was used.
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4.2.5 Exposure and outcome Measures -  Suicidal behaviour
The exposure measure was psychotic symptoms, as assessed by the K- 
SADS. The outcome measure was a history of suicidal behaviour. Suicidal 
behaviour refers to a continuum from suicidal ideation to suicidal plans to 
suicidal acts (Nock et at., 2008). Suicidal behaviour was assessed as part of 
the K-SADS interview. The suicidal behaviour section begins with the 
interviewer asking about whether the individual has ever experienced 
recurrent thoughts of death, before moving on to ask a series of questions to 
assess suicidal ideation, suicidal plans and suicidal acts. Interviews were 
conducted with parents and children separately and parental and children’s 
reports of suicidal behaviour were both used in the analyses.
4.2.6 Statistical analyses
Logistic regression analyses were used to examine the association between 
the outcome measure, suicidal behaviour, and the exposure, psychotic 
symptoms. First, I report univariate associations in terms of odds ratios, 
along with 95% confidence intervals (95%CI) and p-values for the 
association of psychotic symptoms with suicidal behaviour in the general 
population. Second, in order to control for the effect of co-morbid psychiatric 
illness, I report a regression analysis stratified by the presence of psychiatric 
disorder. Third, in order to assess whether psychotic symptoms predict more 
severe forms of suicidal behaviour (suicide plans and acts) in groups at 
higher risk of suicidal behaviour, I report regression analyses stratified by the
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presence of (i) depressive disorders, (ii) behavioural disorders (attention 
deficit/hyperactivity disorder, oppositional defiant disorder and conduct 
disorder) and (iii) suicidal ideation. All analyses were carried out using 
STATA version 11.0 for Windows.
4.3 Neurocognitive assessment
4.3.1 Participants and Methods
The neurocognitive assessment was carried out in years 2 and 3 of the ABD 
study, which included approximately 80% of the total sample (n=165). A 
neurocognitive assessment was not conducted as part of the CT study. The 
MATRICS neurocognitive battery was used (Kern etal., 2008, Nuechterlein 
et al., 2008) with the Wide Range Achievement Test 4 (WRAT-4) (Wilkinson 
and Robertson, 2005) used as a brief assessment of general scholastic 
ability/IQ. Holmen and colleagues have previously reported administering the 
MATRICS in an adolescent sample (ages 12 to 18 years) with early onset 
schizophrenia and showed it to be a sensitive marker of cognitive 
dysfunction in this age group (Holmen etal., 2010). The MATRICS covers 
seven putative domains in ten tests. Because of time constraints, the social 
cognition task was excluded from our panel of tests. The following six 
domains were covered using the nine MATRICS tasks below, with one 
additional task -  the Trail Making Test-Part B (TMT-B).
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Trail making test- Parts A and B (TMT): pencil and paper task which requires 
the participant to draw a line connecting, in consecutive order, numbers 
arranged randomly on a page (Part A), followed by both numbers and letters 
arranged randomly on a page (Part B); outcome: total time for completion.
Brief Assessment of Cognition in Schizophrenia-Symbol coding (BACS-SC): 
a pencil and paper task which requires participants to write numbers that 
correspond to nonsense symbols as rapidly as possible in 90 seconds; 
outcome: number of symbols coded correctly.
Category fluency (Fluency): verbal fluency for animals in 60 seconds; 
outcome: number of correct words spoken.
Hopkins Verbal Learning Test-Revised (HVLT-R): participants heard a list of
12 words and were asked to repeat these in a series of three trials; outcome: 
number of correct responses summed over three trials.
Letter Number Span (LNS) (verbal memory): participants heard sets of 
letters and numbers, which they were required to repeat after mentally 
reordering numerically and alphabetically; outcome: total number correctly 
spoken.
Wechsler Memory Scale-Spatial Span (WMS-SS) (non-verbal memory): 
requires participants to remember and repeat which of a series of blocks the
4.3.2 Tasks
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test administrator points to, first forward then backward; outcome: sum of raw 
scores for both conditions.
Mazes (Neuropsychological Assessment Battery): pencil and paper test 
where participants attempted seven mazes of increasing difficulty; outcome: 
scores were based on the speed with which participants completed the 
seven mazes.
Brief Visuospatial Memory Test-Revised (BVMT-R): participants were shown 
a page displaying six geometric figures for ten seconds over three trials and 
asked to draw these figures on a sheet of paper after each trial. Outcome: 
points were awarded for the accuracy of the drawings over the three trials.
Continuous Performance Test-Identical Pairs (CPT-IP): participants were 
required to monitor numbers as they flashed on screen and press a button 
whenever two numbers in a row were identical; outcome: summed mean d' 
value, which is an index of signal/noise discrimination, across 2-, 3-, and 4- 
digit conditions.
4.3.3 Statistical Analyses
Statistical analyses were conducted using STATA version 11.0 for Windows. 
Means and standard deviations are reported for adolescents with and without 
psychotic symptoms. Standardized Z-scores were calculated for each 
participant across each of the tasks and analysis of covariance (ANCOVA) 
was used to examine neurocognitive performance on the MATRICS in
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adolescents with psychotic symptoms compared to the rest of the population 
sample, controlling for sex and number of years of education.
61
The Psychosis Section of the K-SADS interview was altered to include 
questions covering the five positive symptom sections (P1 to P5) of the 
Structured Interview for Prodromal Syndromes (SIPS). This was to assess 
additional information necessary to diagnose prodromal risk syndromes 
according to the criteria of prodromal syndromes defined by the SIPS 
interview. Questions were also added about the onset and frequency of and 
attributions for symptoms, as well as questions about whether or not 
symptoms caused distress to the interviewee, in order to gain information 
related to the proposed DSM-V diagnosis of ‘Attenuated Psychosis 
Syndrome’ (see Table 4.1 for criteria). The K-SADS interview finished with 
an assessment of the young person’s functioning using the Children’s Global 
Assessment Scale, which is a validated measure of global functioning 
adapted from the Global Assessment Scale for adults (Shaffer et al., 1983).
Three certified SIPS raters (Ian Kelleher, Aileen Murtagh and Mary Cannon), 
trained by a senior clinician from the Yale PRIME Prodrome Research Clinic 
(Barbara Walsh), reviewed all interviews and applied the criteria of prodromal 
syndromes (COPS) in order to confirm risk syndrome diagnoses. Diagnostic 
criteria are included in the Appendix but, briefly, there were 3 possible risk 
syndrome diagnoses:
4.4 Prodromal Risk Syndromes
4.4.1 P artic ipan ts  and M ethods
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Attenuated positive symptoms prodromal syndrome (APSP) is characterized 
by the following: (i) positive psychotic symptoms that are rated as three 
(moderate), four (moderately severe) or five (severe but not psychotic) on the 
P1 to P5 scales, (ii) symptoms began, or worsened by one or more scale 
points, within the past 12 months and (iii) symptoms occurred at least one a 
week in the past month.
Brief intermittent psychotic symptoms prodromal syndrome (BIPS) is 
characterized by the following: (i) positive symptom(s) rated six (i.e., frankly 
psychotic), (ii) symptom(s) have reached a psychotic level of intensity within 
the past three months and (iii) symptom(s) have been present for at least 
several minutes per day at a frequency of at least once per month.
Genetic risk and deterioration prodromal syndrome (GRD) is characterized 
by the following: (i) the participant meets criteria for current schizotypal 
personality disorder or has a first degree relative with a psychotic disorder, 
and (ii) a drop of at least 30% in the Global Assessment of Functioning score 
over the past month as compared to 12 months ago.
We also estimated the prevalence of prodromal risk syndromes/at risk 
mental states according to CAARMS criteria (see Appendix for full CAARMS 
criteria). In addition to criteria on positive psychotic symptoms, the most 
recent edition of the CAARMS added a criterion of a 30% decline in 
social/occupational functioning. CAARMS risk syndrome prevalences are 
reported with and without this criterion in the results.
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Table 4.1: Criteria for the proposed ‘Attenuated Psychosis Syndrome’ for 
DSM-V
a) Characteristic symptoms: at least one o f  the follow ing in attenuated 
form with intact reality testing, but o f  sufficient severity and/or frequency 
that it is not discounted or ignored
(i) delusions
(ii) hallucinations
(iii) disorganized speech
b) Frequency/Currency: symptoms m eeting criterion A  m ust be present in 
the past month and occur at an average frequency o f  at least once per w eek in 
past month
c) Progression: sym ptom s m eeting criterion A  must have begun in or 
significantly worsened in the past year
d) Distress/Disability/Treatm ent Seeking: symptoms m eeting criterion A  
are sufficiently distressing and disabling to the patient and/or parent/guardian 
to lead them to seek help
e) Sym ptom s m eeting criterion A  are not better explained by any D SM -5  
diagnosis, including substance-related disorder
f) Clinical criteria for any D SM -V  psychotic disorder have never been  
met
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Statistical analyses were conducted using STATA version 11.0 for Windows. 
A prevalence figure is reported for prodromal risk syndromes in the 
interviewed sample. Logistic regression was used to examine the 
relationship between risk syndromes and Axis-1 diagnoses. Analysis of 
variance was used to examine the association between risk syndrome status 
and functioning on the Children’s Global Assessment Scale.
4 .5  E th ica l a p p ro v a l
Ethical approval for the ABD study was received from the Beaumont Hospital 
Medical Ethics Committee and for the CT study from the Mater Misericordiae 
University Hospital Medical Ethics Committee. Following complete 
description of the study to participants and their parents, informed consent 
(parents) and assent (children less than 18 years) were received. A 
consultant child and adolescent psychiatrist was available to give guidance 
for cases that raised clinical concerns (Dr Michelle Harley for the ABD study; 
Prof Carol Fitzpatrick for the CT study), such as where suicidal behavior was 
reported, and participants were offered referrals to child and adolescent 
mental health services whenever appropriate. Parents and children were 
given contact details for the research teams, who were available to answer 
any questions or concerns that arose during or after participation in the 
studies.
4.4.2 S ta tis tica l A na lyses
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C h a p t e r  5 : R e s u l t s
P s y c h o tic  s y m p to m s  a n d  A x is-1  p s y c h o p a th o lo g y
5.1 R e s u lts  o f  A B D  S u r v e y  S tu d y
5.1.1 Psychotic symptoms and SDQ-rated psychopathology
Psychotic symptoms were reported by 21 % (n=239) of the early adolescence 
sample in the survey study, based on endorsement of the auditory 
hallucinations question. Increasing ‘total difficulties’ scores on the SDQ were 
associated with increasing odds of reporting psychotic symptoms (F=94.72, 
p<0.001). Adolescents who scored within the top quartile for SDQ-measured 
psychopathology were 6.5 times more likely to report psychotic symptoms 
compared to those in the lowest quartile (test for trend, Z = 8.60, p<0.001) 
(see Table 5.1). In fact, among adolescents with the top 5% most severe 
SDQ total difficulties scores, 48.1% reported psychotic symptoms, in contrast 
to just 2.9% of adolescents with the lowest 5% SDQ total difficulties score 
(OR=31.10, CI95=6.91-140.02, p<0.001). Psychotic symptoms were not 
confined to any one disorder -  rather they were reported at an increased 
prevalence across each of the SDQ-rated emotional, conduct and 
hyperkinetic disorders (see Table 5.2).
5.1.2 Comorbid psychopathology
In order to investigate whether psychotic symptoms were more common in 
adolescents who had SDQ-rated comorbidity across the three disorder
domains (i.e., abnormal on 2 or more of the emotional disorders, conduct
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disorders and hyperkinetic disorders domains), the prevalence of psychotic 
symptoms was calculated among adolescents who screened positive for 
psychopathology on 1, 2 or all 3 of the disorder domains compared to 
adolescents with no disorder. The prevalence of psychotic symptoms among 
those who did not demonstrate psychopathology on any of the 3 domains 
was 15%, but for psychopathology on 1 domain the prevalence of psychotic 
symptoms was 33% (OR=2.71, CI95=1.85-3.98, p<0.001), for 
psychopathology on 2 domains the prevalence of psychotic symptoms was 
43% (OR=4.85, CI95=2.69-8.74, p<0.001) and for psychopathology on all 3 
domains the prevalence of psychotic symptoms was 54% (OR=8.59,
CI95=2.00-36.92, p<0.001) (test for trend: Z = 7.83, p<0.001) (see Figure 
5.1).
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Table 5.1: Odds of experiencing psychotic symptoms according to SDQ psychopathology scores in quartiles (a) unadjusted and
(b) adjusted for sex in the ABD survey study
Quartile N % with psychotic symptoms Early adolescence survey study 
OR (CI95)
(a) (b)
1 313 7.7% 1 1
2 322 18% 2.31 (1.42-3.76) 1.91 (1.10-3.32)
3 221 22.2% 3.00 (1.81-4.97) 2.59 (1.45-4.60)
4 276 38.2% 6.50 (4.09-10.33) 5.50 (3.25-9.30)
Test for trend across quartiles Z—8.60, p<0.001
A B D , Adolescent Brain Development; SDQ, Strengths and Dil faculties Questionnaire
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Table 5.2: Odds of experiencing psychotic symptoms among adolescents with SDQ-rated emotional, hyperkinetic and conduct
disorders (a) unadjusted and (b) adjusted for sex in the ABD survey study
% with psychotic Early adolescence survey study
symptoms OR (CI95)
(a) (b)
Emotional disorders 44% 3.44 (2.33-5.10) 2.98 (1.89-4.69)
Hyperkinetic disorders 35% 2.34 (1.62-3.37) 2.74 (1.80-4.18)
Conduct disorders 36% 2.38 (1.63-3.48) 2.91 (1.85-4.58)
A B D , A dolescent Brain Development; SDQ, Strengths and D ifficulties Questionnaire
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Results o fA B D  and CT Interview Studies
5 .2  P s y c h o tic  s y m p to m s  a n d  P s y c h o p a th o lo g y
5.2.1 Diagnoses of Axis-1 disorders
Thirty one percent of the ABD interview study sample had a lifetime 
diagnosable affective, anxiety or behavioural disorder. The lifetime disorders 
included depressive disorders, including major depressive disorder (MDD) 
and adjustment disorder with depressed mood (15%); behavioural disorders, 
including attention deficit/hyperactivity disorder (ADHD), oppositional defiant 
disorder and conduct disorder (9%); and anxiety disorders, including, 
generalized anxiety disorder, social phobia, separation anxiety disorder and 
obsessive compulsive disorder (14%).
Thirty four percent of the CT interview study sample had a lifetime 
diagnosable affective, anxiety or behavioural disorder. The lifetime disorders 
included depressive disorders, including MDD and adjustment disorder with 
depressed mood (18%); behavioural disorders, including ADHD, oppositional 
defiant disorder and conduct disorder (9%); and anxiety disorders, including 
generalized anxiety disorder, social phobia, separation anxiety disorder, 
obsessive compulsive disorder and panic disorder (11 %).
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5.2.3 Association between psychotic symptoms and Axis-1 
diagnoses in the ABD study
A total of 22.6% (n=53) of the ABD sample reported psychotic symptoms, 
primarily auditory hallucinations. The prevalence of psychotic symptoms was 
higher among males (x2=7.03, p<0.01). Of all adolescents who reported 
psychotic symptoms, 57% had a lifetime diagnosable Axis-1 disorder 
(OR=3.73, CI95=1.97-7.07, p<0.001) and 30.2% had a current diagnosable 
Axis-1 disorder (OR=3.46, CI95=1.64-7.31, p<0.01). Adolescents with a 
lifetime diagnosable affective disorder were 5-times more likely to report 
psychotic symptoms compared to the rest of the sample, while adolescents 
with a lifetime diagnosable behavioural disorder were 3-times more likely to 
report psychotic symptoms (see Table 5.3)
5.2.4 Association between psychotic symptoms and Axis-1 
diagnoses in the CT study
In the mid-adolescence sample, 7% of participants reported psychotic 
symptoms, primarily auditory hallucinations. There was a trend for psychotic 
symptoms to be more prevalent among males (x2=3.62, p=0.057). Of all 
adolescents who reported psychotic symptoms, 79% had a lifetime 
diagnosable Axis-1 disorder (OR=8.19, CI95=2.2-30.4, p<0.01) and 43% had 
a current diagnosable Axis-1 disorder (OR=4.27, 0195=1.38-13.21, p=0.01). 
Adolescents with a lifetime diagnosable affective disorder were more than 
10-times as likely to report psychotic symptoms compared to the rest of the
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sample, while adolescents with a lifetime diagnosable behavioural disorder 
were 5-times as likely to report psychotic symptoms (see Table 5.3).
5.2.5 Multiple psychopathology in the ABD and CT interview 
studies
Multiple psychopathology (that is, a history of more than one Axis-1 
diagnosis) was present in 15% (n=35) of the ABD sample interviewed. A 
dose-response relationship was observed between the number of Axis-1 
diagnoses an adolescent had and their risk of reporting psychotic symptoms 
(Z = 3.67, p < 0.001). In the ABD study, 29% of participants with one 
diagnosable Axis-1 disorder reported psychotic symptoms, compared to 38% 
of participants with two diagnosable disorders and 55% of adolescents with 
three or more diagnosable disorders (see Table 5.4 and Figure 5.1). Multiple 
psychopathology was present in 10% (n=21) of the CT sample interviewed. A 
dose-response relationship was also observed between the number of Axis-1 
diagnoses an adolescent had and their risk of reporting psychotic symptoms 
in this sample (Z = 4.29, p < 0.001). Eight percent of participants with one 
diagnosable Axis-1 disorder reported psychotic symptoms, compared to 31% 
of participants with two diagnosable disorders and 40% of participants with 
three or more diagnosable disorders (see Table 5.4 and Figure 5.1).
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Table 5.3: Odds of experiencing psychotic symptoms among adolescents with lifetime DSM IV Axis-1 diagnoses diagnosed by
clinical interview (a) unadjusted and (b) adjusted for sex in the ABD interview study and the CT interview study
Diagnosis % with psychotic 
symptoms
A B D  interview study OR (CI95) 
(a) (b)
% with psychotic  
symptoms
CT interview study OR (CI95) 
(a) (b)
A ny lifetim e Axis-1  
disorder
40% 2.89 (1.54-5.41) 2.89 (1.52-5.48) 19% 11.15 (2.99-41.65) 11.94 (3.14-45.41)
A ffective disorders 51% 4.93 (2.31-10.51) 5.08 (2.33-11.07) 24% 10.67 (3.33-34.19) 12.33 (3.69-41.19)
Behavioural disorders 50% 3.95 (1.55-10.10) 3.23 (1.24-8.43) 22% 5.14 (1.43-18.51) 4.55 (1.23-16.75)
A nxiety disorders 23% 0.99 (0.48-2.06) 1.01 (0.48-2.12) 9% 1.45 (0.30-6.95) 1.67 (0.24-1.55)
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Table 5.4: Odds of experiencing psychotic symptoms in adolescents with one, two or three or more comorbid DSM-IV Axis-1 
disorders diagnosed by clinical interview, (a) unadjusted and (b) adjusted for sex, in the ABD interview study and the CT 
interview study
Diagnosis % with psychotic 
symptoms
A BD  interview study 
OR (CI95)
(a) (b)
% with psychotic 
symptoms
CT interview study 
OR (CI95)
(a) (b)
One disorder only 29% 2.25 (1.06-4.75) 2.27 (1.06-4.87) 8% 3.86 (0.83-17.88) 4 .1 2 (0 .8 8 -1 9 .3 8 )
Two disorders 
only
38% 3.23 (1.27-8.27) 3.18 (1.22-8.29) 31% 20.15 (4.24-95.59) 18.33 (3.77-89.15)
Three or more 
disorders
55% 6.47 (1.82-22.98) 6.31 (1.73-23.05) 40% 29.56 (3.53-247.17) 36.18 (3.94-332.06)
Test for trend Z =  3.67, p <  0.001 Z =  4.29, p <  0.001
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Figure 5.1: Prevalence of psychotic symptoms by comorbid diagnoses in the ABD survey sample (green line), ABD interview 
sample (blue line) and CT interview sample (red line)
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5.3 Psychotic symptoms and suicidal behaviour
5.3.1 Prevalence of suicidal behaviour and association with 
psychotic symptoms
Findings on the association between psychotic symptoms and suicidal 
behaviour are shown in Table 5.5. Seven percent of the ABD sample 
reported suicidal behaviour. Specifically, 6.8% (n=16) reported suicidal 
ideation, 3.7% (n=5) reported specific suicide plans and just one participant 
reported a suicidal act (0.4%). Adolescents who reported psychotic 
symptoms demonstrated a greater than 10-fold increased risk of suicidal 
behaviour.
Thirteen percent of the CT sample reported suicidal behaviour. Specifically, 
13.2% (n=28) reported suicidal ideation, 5% (n=11) reported specific suicide 
plans and 3.3% (n=7) reported a suicidal act. Adolescents who reported 
psychotic symptoms demonstrated a greater than 10-fold increased risk of 
suicidal behaviour (see Table 5.5).
5.3.2 Stratification by psychiatric disorder
A diagnosable psychiatric disorder was also associated with increased risk 
for suicidal behaviour (ABD study: OR=3.09, CI95=1.08-8.83, p<0.05; CT 
study: OR=7.6, 095=3.17-18.06, p<0.001). Therefore, in order to examine 
the relationship between psychotic symptoms and suicidal behaviour in this 
higher risk group, and in order to allow extrapolation to clinical populations,
we conducted secondary analyses limited to adolescents with a history of
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diagnosable psychiatric disorder. Results are shown in Table 5.5. In the ABD 
study, adolescents with a diagnosable psychiatric disorder plus psychotic 
symptoms were at a greater than 5-fold increased risk of suicidal behaviour 
compared to adolescents with a diagnosable psychiatric disorder but no 
psychotic symptoms. In the CT study, adolescents with a diagnosable 
psychiatric disorder plus psychotic symptoms were at a greater than 5-fold 
increased risk of suicidal behaviour compared to adolescents with a 
diagnosable psychiatric disorder but no psychotic symptoms.
5.3.3 Stratification by suicidal behaviour severity: suicide plans 
and acts
Because suicidal behaviour varies in severity, with ideation on one end and 
other forms -  suicide plans and acts -  further along the continuum of 
severity, we conducted a further set of analyses to assess the risk for more 
severe behaviour - suicide plans and acts. As the ABD study contained a 
younger age group (mean age 11.5 years) and did not enrich for suicidal 
behaviour, there were few cases of severe suicidal behaviour; however, the 
CT data, with its older population and enrichment for suicidal behaviour, 
facilitated this analysis. Adolescents with a diagnosis of a depressive 
disorder or a behavioural disorder and adolescents with suicidal ideation 
were all more likely to have suicide plans or acts. In order to test whether 
psychotic symptoms helped to differentiate adolescents in these diagnostic 
groups who had suicide plans or acts from those who did not, we conducted 
a number of stratified analyses. Among adolescents with (i) depressive
disorders and (ii) behavioural disorders, adolescents who reported psychotic
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symptoms were at greatly increased risk for suicidal plans and acts 
compared to adolescents with the same diagnoses who did not report 
psychotic symptoms (see Table 5.6). Among adolescents with suicidal 
ideation, psychotic symptoms were associated with a 20-fold increased risk 
for suicide plans and acts. Strikingly a majority of adolescents with suicidal 
plans or acts reported psychotic symptoms when they were directly 
questioned about this in both the ABD (80%) and CT (55%) studies.
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Table 5.5: Psychotic symptoms and odds of suicidal behaviour in 2 population samples ages 11-13 years (ABD study) and 13-15 
years (CT study) (a) unadjusted and (b) adjusted for sex
All suicidal behaviour
(a)
OR (CI95)
P All suicidal behaviour 
(b)
OR (CI95)
P
ABD study population sample (n=212) 9.01 (2.97-27.33) 0.000 10.23 (3.25-32.26) 0.000
CT study population sample (n=211) 8.52 (2.21-32.91) 0.002 10.50 (3.14-35.17) 0.000
ABD study sample with diagnosable psychiatric disorder (n=78) 5.27 (1.25-22.23) 0.023 5.13 (1.15-22.81) 0.032
CT study sample with a diagnosable psychiatric disorder (n=72) 4.37 (1.14-16.79) 0.031 5.31 (1.29-21.84) 0.021
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Table 5.6: Prevalence and odds of suicide plans and acts among stratified samples of mid adolescence (CT) study (a) unadjusted 
and (b) adjusted for sex
Prevalence o f suicide 
plans or acts -  
no psychotic 
symptoms
Prevalence o f suicide 
plans or acts -  
psychotic symptoms
OR (CI95) OR (CI95)
CT sample with depressive disorder (n=37) 16% 67% 10.4 (1.9 to 56.0) 13.7 (2.1 to 89.6)
CT sample with behavioural disorder (n=18) 0% 75% 00 oo
CT sample with suicidal ideation (n=28) 24% 86% 19.2 (1.8 to 
200.0)
19.6 (1.8 to 
216.1)
oo odds ratio not calculable because 0 participants in comparison group
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Adolescents with psychotic symptoms did not differ in general scholastic 
ability/IQ as measured with the W RA T-4 (F=0.02, df=1, p=0.89). In tests of 
neurocognitive function, adolescents with psychotic symptoms performed 
significantly more poorly on three tests of processing speed: TM T-A (F=3.33, 
p<0.05), TM T-B (F=3.06, p<0.05) and BACS symbol coding (F=7.03, 
p<0.001). Adolescents with psychotic symptoms also performed more poorly 
in their non-verbal working memory: W M S spatial span task (F=3.17, 
P<0.05). Differences on the HVLT-R were just outside statistical significance 
at the level of p=0.05. See Table 5.7 and Figure 5.2 for details.
5.4 Psychotic symptoms and Neurocognition
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Table 5.7: Neurocognitive perform ance on the MATRICS battery, adjusted for sex and years of education
Test
(Putative neurocognitive domain)
Males 
(n=85) 
Mean (sd)
Females 
(n=80) 
Mean (sd)
F
(p value)
Psychotic 
symptoms 
group (n=42) 
Mean (sd)
Comparison 
group 
(n=123) 
Mean (sd)
F
(p value)
TMT-A*
(Processing speed)
44.9 (13.3) 41.8 (12.1) 2.47
(0.12)
45.5 (14.0) 42.6 (12.3) 3.33
(<0.05)
TMT-B*
(Processing speed)
74.3 (29.0) 68.3 (28.8) 1.46
(0.23)
83.4 (32.3) 67.4 (26.8) 3.06
(<0.05)
BACS:SC 
(Processing speed)
45.5 (9.4) 50.3 (8.6) 11.66
(<0.001)
44.4(10.2) 49.1 (8.7) 7.03
(<0.001)
Category Fluency 
(Processing speed)
20.2 (5.4) 20.1 (4.9) 0.01
(0.91)
19.8 (5.2) 20.3 (5.2) 1.20
(0.31)
HVLT-R
(Verbal learning/memory)
24.6 (4.2) 26.0 (4.5) 3.71
(0.06)
24.3 (5.3) 25.6 (4.0) 2.59
(0.05)
WMS spatial span 
(Working memory: nonverbal)
14.7 (3.1) 15.9 (3.1) 6.89
(<0.01)
14.9 (3.7) 15.4 (2.9) 3.17
(<0.05)
LNS
(Working memory: verbal)
13.1 (2.8) 13.5 (2.9) 0.84
(0.36)
13.4 (2.9) 13.3 (2.8) 0.37
(0.78)
NAB: Mazes
(Reasoning and problem solving)
16.5 (5.1) 14.9 (5.0) 3.97
(<0.05)
15.2 (5.1) 15.9 (5.1) 2.38
(0.07)
BVMT-R 
(Visual learning)
25.1 (7.9) 27.5 (6.6) 4.56
(<0.05)
26.9 (7.0) 26.1 (7.5) 2.24
(0.09)
CPT-IP
(Attention/Vigilance)
5.0 (4.8) 5.4 (1.7) 0.24
(0.63)
4.5 (2.8) 5.3 (4.0) 0.27
(0.85)
*Higher score = poorer performance. Abbreviations: sd, standard deviation; TMT, Trail Making Test (Part A and Part B); BACS:SC, 
Brief Assessment of Coding in Schizophrenia: Symbol Coding; HVLT-R, Hopkins Verbal Learning Test -  Revised; WMS, Wechsler 
Memory Scale; LNS, Letter Number Span; NAB, Neuropsychological Assessment Battery; BVMT-R, Brief Visuospatial Memory Test 
-  Revised; CPT, Continuous Performance Test -  Identical Pairs
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neurocognitive battery.
TMT-A, Trail Making Test-Part A; TMT-B, Trail Making Test-Part B; BACS:SC, Brief Assessment o f Coding in Schizophrenia: 
Symbol Coding; Fluency, Verbal fluency test (animal naming); HVLT-R, Hopkins Verbal Learning Test -  Revised; WMS:SS, 
Wechsler Memory Scale: Spatial Span; LNS, Letter Number Span; Mazes, Neuropsychological Assessment Battery: Mazes; BVMT-R, 
Brief Visuospatial Memory Test -  Revised; CPT, Continuous Performance Test -  Identical Pairs
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5.5 Prodromal Risk Syndromes
5.5.1 Prevalence o f risk syndromes
Applying SIPS criteria to adolescents who reported psychotic symptoms, 
8.1%  (n=19) of the total sample met criteria for a current prodromal risk 
syndrome. Specifically, 7.7% met criteria for an attenuated positive 
symptoms prodromal syndrome (APSP) and 3.5% met criteria for a brief 
intermittent psychotic symptoms prodromal syndrome (BIPS). One additional 
participant met criteria for APSP in remission. Three participants had a first 
degree relative with a psychotic disorder but none of these participants had 
experienced a significant decline in functioning within the past year and so 
no participant met criteria for GRD. There was no significant effect of age or 
socioeconomic status on risk syndrome status. However, significantly more 
males than females fulfilled criteria for a risk syndrome (x2=4.17, p=0.04).
Applying the CAARMS criteria, 7.7% of the sample met criteria for an at risk 
mental state without applying a criterion of a 30% decrease in functioning in 
the last year. Just 0.9% (n=2) of participants would have met criteria for an at 
risk mental state, however, were a 30% decrease in functioning used as an 
obligate criterion (using the Children’s Global Assessment Scale as the 
measure of functioning).
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5.5.2 Attenuated Psychosis Syndrome
The proposed DSM-V diagnosis of attenuated psychosis syndrome (see 
Table 4.1) differs from APSP in Criterion D, that is, the requirement that, in 
addition to attenuated psychotic symptoms, there is also distress and 
disability. The majority of adolescents who fulfilled criteria for APSP, in fact, 
did report being distressed by their symptoms (89%). Similarly, in terms of 
disability, adolescents who fulfilled criteria for APSP also demonstrated 
significantly impaired functioning compared to controls, as measured by the 
Children’s Global Assessment Scale (F=24.5, df=1, p<0.0001).
5.5.3 Prodromal Risk Syndromes and Psychiatric Com orbidity
A total of 63% of the adolescents who met criteria for a prodromal risk 
syndrome also met criteria for at least one lifetime Axis-1 diagnosis 
(OR=4.77, C I95=1.81 -  12.52; p<0.01) (see Table 5.8). The most common 
lifetime Axis 1 diagnosis was major depressive disorder (MDD) (26%). Thirty 
seven percent of adolescents with risk syndromes met criteria for a 
depressive disorder, 32% met criteria for an anxiety disorder and 21% met 
criteria for a behavioural disorder. Furthermore, 30% reported current or past 
suicidal ideation and 20% reported a history of self harm.
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Table 5.8: Lifetime Axis 1 diagnoses and suicidal behaviour in patients with
prodromal risk syndromes and in controls
Lifetime Axis 1 diagnosis Prodromal risk 
syndrome 
(n=19)
Controls
(n=193)
Any diagnosis 63% 28%
Affective disorders 37% 13%
Major Depressive Disorder 26% 5%
Dysthymic disorder 0 0.5%
Adjustment disorder with 
depressed mood
16% 8.4%
Behavioural Disorders 21% 7%
Attention Deficit/Hyperactivity 
Disorder
16% 4%
Oppositional Defiant Disorder 5% 4%
Conduct Disorder 0 1%
Anxiety Disorders 16% 13%
Generalized Anxiety Disorder 0 6%
Separation anxiety disorder 5% 5%
Avoidant disorder 5% 2%
Obsessive Compulsive 
Disorder
5% 2%
Social phobia 5% 5%
Suicidal ideation 30% 5%
8 6
Self-harm 2 0 % 6 %
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C h a p t e r  6 :  D i s c u s s i o n
Using one large population-based survey study and two in-depth clinical 
interview studies, a number of significant findings have emerged. First, 
psychotic symptoms are prevalent in a wide range of non-psychotic 
psychopathologies. Second, while psychotic symptoms are not 
pathognomonic of illness, the majority of young people in the community 
who report psychotic symptoms do have a diagnosable psychiatric disorder. 
Third, psychotic symptoms index particularly high risk for multiple pathology, 
that is having more than 1 DSM diagnosis. Fourth, psychotic symptoms are 
reported more commonly in early compared to middle adolescence. Fifth, 
psychotic symptoms become increasingly predictive of diagnosable 
psychopathology with increasing age.
While some research has shown that the majority of psychotic symptoms in 
childhood are transient, with symptoms that persist over time thought to be 
of more clinical significance (van Os e t  a l. , 2009), in the current study the 
majority of adolescents who reported psychotic symptoms had at least one 
diagnosable Axis-1 psychiatric disorder, regardless of the issue of psychotic 
symptom persistence. Increased risk for psychopathology was not related to 
a particular diagnosis or even one group of disorders; rather, a variety of 
Axis-1 disorders were associated with psychotic symptoms. Interestingly,
6.1 Psychotic symptoms and Axis-1 psychopathology
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however, psychotic symptoms demonstrated a particularly strong 
relationship with more severe psychopathology, with prevalence of psychotic 
symptoms increasing in a dose-response fashion with the number of 
diagnosable disorders. In the CT study, for example, 40% of adolescents 
with three or more comorbid disorders reported psychotic symptoms, 
compared to just 8% of adolescents with only one disorder
Psychotic symptoms were more common in the early adolescence samples 
(21% to 23%) compared to middle adolescence (7%). This is in line with the 
meta-analytic findings in the current thesis of a decline in prevalence of 
psychotic symptoms from childhood into adolescence. However, 
associations between psychotic symptoms and diagnosable disorder were 
stronger in the older sample compared to the younger samples. While 57%  
of the early adolescence (ABD study) sample who reported psychotic 
symptoms had a diagnosable psychiatric disorder, nearly 80% of the mid 
adolescence (CT study) sample who reported psychotic symptoms had at 
least 1 diagnosable disorder. In a study of younger children, aged 7 to 8, 
Bartels-Velthuis and colleagues found that auditory hallucinations were 
associated with only a minor increase in risk for parent-reported behavioural 
and emotional symptoms (Bartels-Velthuis e t  a l. , 2010) but that at age 12 to
13 years psychotic symptoms predicted an approximately 3- to 5-fold 
increased risk of scoring in the clinical range of the Child Behaviour 
Checklist (Bartels-Velthuis e t  a l. , 2011). Hallucinatory and delusional
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experiences, then, may fall somewhat within the normal spectrum of 
experience in early childhood but might be expected to discontinue in the 
course of development. Psychotic symptoms in adolescence, the current 
findings suggest, become increasingly associated with psychopathology -  in 
particular with severe, multiple co-occurring disorders.
There are a number of possible explanations as to how psychotic symptoms 
act as a marker for a wide range of psychopathology. One possibility is that 
the same risk factors may predispose to both psychotic symptoms and 
psychiatric illness. In fact, Breetvelt et al. have recently demonstrated that 
many risk factors that have typically been considered risk factors for 
psychosis are risk factors for a wider range of (non-psychotic) 
psychopathology (Breetvelt e t  a l. , 2010). It is also possible that mental 
distress caused by psychotic symptoms contributes to, for example, 
depressive thoughts or behavioural symptoms. It may also be the case, 
however, that psychotic symptoms do not contribute to psychopathology per 
se but, rather, emerge in vulnerable individuals who experience non- 
psychotic psychopathology and therein act as a marker, rather than an 
aetiological factor, for non-psychotic psychopathology.
The limited structural and functional magnetic resonance imaging (MRI) 
research on psychotic symptoms to date suggests that adolescents with 
psychotic symptoms exhibit a profile of subtle neurodevelopmental
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differences that shares features with a number of psychiatric disorders 
(Jacobson e t  a l. ,  2010). A recent meta-analysis of brain volume 
abnormalities in major depressive disorder, for example, showed that the 
greatest changes occur in two regions important in emotion processing and 
stress regulation -  the cingulum and orbitofrontal cortex (Koolschijn e t  a l. ,
2009), both of which we have recently shown to be abnormal in adolescents 
with psychotic symptoms (Jacobson e t  a l. ,  2010). Using functional MRI and 
digital tractography, Jacobson et al. also demonstrated reduced activity 
within the right frontal and bilateral temporal cortices during response 
inhibition tasks and overall reduced integrity of fronto-temporal pathways in 
adolescents with psychotic symptoms, supporting a profile of a relative 
disinhibition/pro-impulsivity phenotype. These neurobiological findings mirror 
the clinical findings of increased affective and behavioural disorders in the 
current thesis.
Strengths and limitations
There are a number of strengths to the current work, most notably the use of 
three studies, each of which shows the same pattern of results. While the 
larger survey study allowed testing for relationships between psychotic 
symptoms and psychopathology in terms of a symptomatic continuum, the 
downside of this approach is that clinical implications, in the absence of 
actual diagnoses, can be hard to draw. However, the use of two clinical 
interview studies allows us to draw clear clinical Implications by exploring the
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relationship between psychotic symptoms and actual psychiatric diagnoses. 
The use of multiple studies also allowed an examination of the relationship 
between psychotic symptoms and psychopathology from early through 
middle adolescence. In addition, the use of community samples is 
particularly valuable because findings are generalisable to the population. A 
limitation is that the issue of temporality cannot be resolved, i.e., which came 
first: psychotic symptoms or psychopathology, or, indeed, did both arise 
together. However, this does not detract from the clinical utility of 
understanding the contemporaneous relationship between psychotic 
symptoms and non-psychotic psychopathology. Subgroup analyses within 
studies means that there are small groups and confidence intervals, as a 
result, are wide in some cases. However, the same pattern of results was 
found across all three studies showing that the findings are robust.
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The results of two Independent epidemiological studies showed that 
psychotic symptoms index large increases in risk for (i) suicidal behaviour in 
the general adolescent population, (ii) suicidal behaviour in adolescents with 
psychiatric disorders and (iii) more severe forms of suicidal behaviour 
(suicidal plans and acts) among adolescents with depressive disorders, 
behavioural disorders and suicidal ideation. In fact, in both studies, psychotic 
symptoms were reported by the majority of adolescents who reported having 
formulated specific suicide plans or previous suicidal acts. This is a 
particularly important fact given that suicide plans and history of parasuicide 
have been shown to be among the most predictive risk factors for completed 
suicide (Powell e t  a !. , 2000, Suominen e t  a l. , 2004).
There are a number of possible explanations as to the mechanisms 
underlying the strong relationship between psychotic symptoms and suicidal 
behaviour. The most obvious is that hallucinations may direct the individual 
to harm or kill themselves. In fact, a post-hoc analysis of the type of 
psychotic symptoms reported by adolescents with suicidal behaviour 
demonstrated that all included auditory hallucinations. However, only one of 
the participants in either of the studies reported command hallucinations to 
harm or kill themselves. It is possible, however, that psychotic symptoms 
may impact on suicidal behaviour via indirect cognitive mechanisms. 
Changes in the subjective sense of self, for example, are amongst the
6.2 Psychotic Symptoms and Suicidal Behaviour
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Yung e t  a l. , 1996) and a sense of disintegration and fragmentation of the self 
resulting from intrusive voices has long been linked to suicidal thinking 
(Bleuler, 1911, Frosh, 1983). Similar effects may occur in the extended 
psychosis phenotype -  Bleuler’s concept of the ‘suicidal drive’ might not be 
just the most severe symptom of schizophrenia (Bleuler, 1911) but the most 
severe symptom of a much broader psychosis phenotype made up of 
individuals in the general population who experience psychotic symptoms.
Common causes shared between psychotic symptoms and suicidal 
behaviour may be part of the mechanism underlying the striking relationship 
between the two variables. Individuals with mental disorders who experience 
psychotic symptoms, for example, may be more unwell in general than 
individuals with mental disorders who do not experience psychotic 
symptoms. This is supported by the finding in the current thesis that 
adolescents with a psychiatric disorder who reported psychotic symptoms 
were significantly more likely to have a second co-occurring disorder. These 
symptoms, then, may be an important marker of deteriorating mental health 
in a way that indexes high risk for suicidal behaviour. Jacobson et al. 
recently showed volumetric differences in the cingulum and orbitofrontal 
cortex in a sample of adolescents with psychotic symptoms (Jacobson e t  a l.,  
2010), two centres that are known to play important roles in emotion 
processing and stress regulation (Koolschijn e t  a l. , 2009). Abnormalities in
earliest recognizable symptoms of psychosis (Klosterkotter et  al., 1997,
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the orbitofrontal cortex have also recently been highlighted as an area of 
interest in magnetic resonance imaging (MRI) studies of suicidal patients 
(Monkul e t  a i ,  2007). Furthermore, the clinical findings of the current thesis 
showed that depressive and behavioural symptoms and disorders were 
prevalent among young people with psychotic symptoms. In terms of suicidal 
behaviour, the combination of depressive and impulsive traits poses a high 
risk phenotype.
For clinicians, these findings highlight the importance of a thorough 
assessment of psychotic symptoms in patients presenting with suicidal 
behaviour. Young people rarely volunteer information on psychotic 
symptoms unless questioned directly about such experiences. The 
experience from ABD study interviews, however, is that adolescents are 
usually willing to talk openly about their experiences in response to direct but 
sensitive questioning. This is especially important in child mental health 
clinics, where psychosis can sometimes be seen as an ‘adult psychiatry’ 
issue and therefore not fully explored. For researchers, these findings 
highlight a complex novel aspect in the study of the aetiology of suicidal 
behaviour.
While the current report includes participants in early and middle 
adolescence, suicidal behaviour in childhood and adolescence predicts 
suicidal behaviour throughout the lifecourse. Reinherz and colleagues, for
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example, showed that adolescents who reported suicidal ideation were, at 
age 30, 15-times more likely to report suicidal ideation and 12-times more 
likely to have attempted suicide (Reinherz e t  a l. ,  2006). Therefore the 
association between suicidal behaviour and psychotic symptoms in 
adolescence is likely to continue into adulthood. Whether or not psychotic 
symptoms are as prevalent in individuals who demonstrate suicidal 
behaviour in adulthood, however, remains to be investigated.
Strengths of the current work include that assessments involved in-depth 
clinical interview and that it was possible to test interactions between 
psychotic symptoms and psychiatric disorders in predicting suicidal 
behaviour. In addition, findings were replicated across two independent 
studies. The age ranges of participants was also complementary across the 
two studies, demonstrating the relationship between psychotic symptoms 
and suicidal behaviour from early through to middle adolescence (ages 11 to 
15 years). As with the psychopathology results above, subgroup analyses for 
suicidal behaviour involved relatively small groups and, because of this, 
confidence intervals are wide. Both studies, however, showed the same 
strong relationship between psychotic symptoms and suicidal behaviour, 
demonstrating that this is a robust finding. Further research on the 
relationship between psychotic symptoms and suicidal behaviour, however, 
will be valuable. Further work is also needed to investigate the relationship
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between psychotic symptoms and suicidal behaviour in later adolescence 
and into adulthood.
97
Adolescents with psychotic symptoms demonstrated processing speed 
deficits using the TMT-A, the TMT-B and the BACS digit symbol coding 
tasks, and (non-verbal) working memory deficits on the W MS spatial span 
task. Processing speed has been suggested to be the core neurocognitive 
deficit of psychosis (Dickinson, 2008, Dickinson e t  a l. , 2007). The results of 
the current study reflect findings in a treatment-naive, extended psychosis 
phenotype and support the hypothesis that a deficit in processing speed is at 
the core of neurocognitive dysfunction in psychosis. Working memory 
deficits were also apparent in this sample, demonstrating the centrality of 
this deficit to the broad psychosis phenotype, though these deficits were less 
pronounced than those of processing speed.
This is the first study to report on symbol coding in a population sample with 
psychotic symptoms, with strong findings of impairment demonstrated on 
this task. This is in keeping with findings from Dickinson et al., who have 
argued that symbol coding deficits in particular reflect slowed information 
processing that is the central feature of cognitive dysfunction in psychosis 
(Dickinson e t a l . ,  2007). Interestingly, in a longitudinal study, Niendam and 
colleagues showed a number of neurocognitive deficits at age 7-years in 
both individuals who would go on to develop schizophrenia and in their 
siblings (Niendam e t  a l. ,  2003); however, only symbol coding scores 
differentiated those who would later develop schizophrenia from their
6.3 Psychotic Symptoms and Neurocognition
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unaffected siblings. Adolescents with psychotic symptoms also 
demonstrated deficits in TMT-A and TMT-B performance in the current 
study. This is in line with a previous cohort study, which demonstrated that 
childhood performance on processing speed tasks (TMT and verbal fluency 
tasks), uniquely among tests of neurocognition, predicted adulthood 
schizophrenia (Cannon e t  a/., 2006). This finding is also in keeping with a 
previous report on a small sample of adolescents with psychotic symptoms 
(n=17), which showed poorer performance on the TMT-B (Blanchard e t a l . ,  
2010).
The significance of processing speed deficits to ‘real world’ measures of 
function has recently been highlighted. Using the Specific Level of Function 
Scale, an observer-rated assessment of a patient’s behaviour and 
functioning, Bowie and colleagues found that processing speed tasks, 
uniquely in a battery of neurocognitive tests, predicted functioning in all three 
domains of functioning, including interpersonal relationships, community 
involvement and work skills, among a sample of more than 200 
schizophrenia patients (Bowie e t  a/., 2008). More recently, among a sample 
of patients at ultra high risk for psychosis, Carrion and colleagues showed 
that both social and role functioning related specifically to processing speed 
(a combined symbol coding and TM T score) and argued that processing 
speed represents a rate-limiting step in the formation of good social and role 
functioning (Carrion e t  a !. , 2011). The community findings in the current
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study suggest that deficits in processing speed may represent an early 
neurocognitive marker of psychosis vulnerability, present not only in 
psychosis patients but even in community-based young adolescents with 
psychotic symptoms.
In contrast to many neurocognitive tasks that might be attributed to specific 
neural networks or specific anatomical regions, processing speed tasks have 
been argued to measure a ‘systems’ based process, reflecting speeded 
integration and coordination between distributed brain networks (Dickinson, 
2008). Recent empirical support for this has come from digital tractography 
imaging of white matter microstructural organization in both healthy and 
brain injured individuals. Turken et al., for example, showed that processing 
speed is closely related to the structural integrity of major white matter tracts 
that run along the anterior-posterior axis of the brain, allowing fronto- 
posterior network interactions, including the superior longitudinal fasciculus, 
occipito-frontal fasciculus and inferior longitudinal fasciculus (Turken e t a ! . ,  
2008). The findings of the current study, then, are in line with the 
dysconnection hypothesis of schizophrenia, which asserts that impaired 
communication within the brains of schizophrenia patients occurs when there 
is focal disruption that adversely affects the entire network (Friston and Frith, 
1995, Weinberger e t  a l. , 1992). This is in keeping with neuroimaging 
findings, described above, which showed impaired connectivity in a 
community sample of adolescents with psychotic symptoms (Jacobson e t  a l. ,
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2010). Processing speed deficits, then, may point to aberrant functional 
connectivity within and between whole-brain neural systems, rather than 
indexing impairment in discrete neural networks.
This is the largest population-based neurocognitive assessment of young 
people with psychotic symptom to date. In addition, this is the first 
epidemiological study in children to use the MATRICS battery. The use of a 
standardized neurocognitive battery in the current study will facilitate 
comparison with other studies. None of the adolescents in the current study 
had a diagnosis of a psychotic disorder and none had ever used 
antipsychotic medication, outruling disease chronicity or treatment effects 
(Knowles e t  a l. ,  2010) in the relationship between psychotic symptoms and 
neurocognitive performance. Further neurocognitive work in this population 
will help to elucidate the underlying pathophysiology associated with risk for 
psychosis.
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6.4 Prodromal Syndromes
Up to 8% of the ABD sample fulfilled criteria for diagnosis of a current 
prodromal risk syndrome. The findings of the current work suggest that there 
are many prospectively identifiable individuals with prodromal risk 
syndromes in the community who have not presented to clinical services. 
What proportion of these individuals would ultimately present to services is 
unknown. However, while the overwhelming majority of cases of new onset 
psychosis have been established to be preceded by a prodromal period 
(Jackson e t a l . ,  1995, Schultze-Lutter e t a i ,  2010, Yung and McGorry,
1996), only a minority of cases of the population-wide incidence of psychosis 
emerge in patients from prodrome risk syndrome clinics, which suggests that 
many such individuals will not clinically present prior to illness onset.
Attenuated positive symptoms prodromal syndrome (APSP), as described, 
differs from the proposed DSM-V diagnosis of ‘Attenuated Psychosis 
Syndrome’ in Criterion D (“distress/disability/treatment seeking”). However, 
the majority of adolescents meeting criteria for APSP reported distress as a 
result of their symptoms and this group demonstrated significantly poorer 
functioning on the Children’s Global Assessment Scale. BIPS diagnoses, 
which usually constitute a relatively small proportion of patients seen in 
prodromal risk syndrome clinics, were present in 40% of all risk syndromes 
in the current study. Interestingly, in the clinic, risk for psychosis has been
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demonstrated to be particularly high for patients with BIPS, with a faster 
onset of psychosis compared to young people with APSP (Nelson e t  a l. ,
2011). It is possible that fewer BIPS patients will present clinically during the 
prodrome and are more likely to present for the first time during first episode 
psychosis due to what appears to be a shorter prodromal period. It is also 
possible that, because the symptoms are ‘brief and ‘intermittent’, that 
patients believe their symptoms have resolved and are, as a result, less 
likely to seek help. Further research will be necessary to understand this 
difference between the clinic and the community.
Non-psychotic psychiatric disorders were present in a large majority of 
adolescents with prodromal risk syndromes, consistent with research on 
clinically-presenting individuals (Addington e t  a l. ,  2011). Rosen et al., for 
example, reported that in a sample of clinically presenting individuals who 
met criteria for a prodromal risk syndrome, 76% had at least one 
diagnosable lifetime Axis 1 disorder (Rosen e t  a l. , 2006). Svirskis et al., 
similarly, reported that over 90% of help-seeking individuals who met criteria 
for a prodromal risk syndrome had at least one comorbid disorder (Svirskis 
e t  a l. , 2005). Depressive disorders were the most common diagnosis in both 
studies, as in the current report. Lencz et al., using the same diagnostic 
instrument as the current study to assess for Axis-1 psychopathology in a 
sample of putatively prodromal help seekers, found MDD to be the most
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common diagnosis, followed by attention deficit/hyperactivity disorder, in 
keeping with the current community findings (Lencz e t  a l. , 2004).
There are a number of implications of this research in relation to the 
proposed DSM-V diagnosis of attenuated psychosis syndrome. Findings 
from the current study that might support this diagnosis include that (i) a 
large majority of the individuals identified are distressed by their symptoms; 
(ii) this group demonstrates significantly poorer global functioning; and (iii) 
the majority of these adolescents have other diagnosable psychopathology 
that suggests that they as a population are truly in need of care. On the other 
hand, the findings of the current study also raise a number of concerns or 
limitations with regard to creation of an ‘attenuated psychosis syndrome’ 
diagnosis, including that (i) the proposed diagnostic criteria are applicable to 
a relatively large proportion of adolescents, meaning that, following 
publication of DSM-V, many young people could suddenly be imposed with a 
stigmatizing diagnosis that they did not previously have; (ii) we do not know 
the relative risk for psychosis among this group since longitudinal community 
research has not been conducted. Given the high prevalence of the 
syndrome, however, it is unlikely to approach the level of risk observed in 
help-seeking samples reported on to date; thus, we risk greatly increasing 
the rate of false positives; (iii) since the majority of these individuals already 
have psychiatric disorders, there would not, in most cases, appear to be a 
major financial barrier to receiving psychiatric treatment in healthcare
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systems that require a formal diagnosis for insurance purposes; (iv) the 
proportion of adolescents who fulfil criteria for a risk syndrome varies greatly 
depending on how ‘disability’ is interpreted in terms of the degree of 
functional decline, something that is not currently specified in the proposed 
criteria; and (v) ‘attenuated psychosis syndrome’ may be a misnomer for a 
syndrome that is, in fact, associated with a wide range of (non-psychotic) 
disorders.
It is important to note that none of the participants in the current study, 
despite meeting criteria for prodromal risk syndromes, had presented to a 
prodrome or other healthcare clinic and so none of the participants can be 
considered ‘help seekers’ in the same way as individuals who have been 
reported on to date in clinic-based research. Why some individuals who 
meet risk syndrome criteria present to clinics while others do not is unclear 
and will require further research. There are many possible reasons for this. 
As already speculated, given the high proportion of BIPS in the current 
community study compared to the proportion of BIPS in clinic-based studies, 
it is possible that young people with BIPS are less likely to present to the 
clinic. The young age of participants in the current study may also be a 
contributing factor. Although, in our experience, even at this age, young 
people are very aware that these experiences are unusual, it is possible that 
younger individuals are less likely to attend their doctor or other health 
professional compared to older teenagers and young adults. Education
105
around psychotic symptoms and psychosis risk syndromes may also be a 
factor. Addington et al., for example, showed that, following an extensive 
community education program, referrals to prodrome services increased 
(Addington e t a l . ,  2008). Thus, a lack of community education and confusion 
about 'where to turn for help’ with these unusual experiences may play a role 
in non-presentation. There may be multiple other differences between help- 
seeking and non-help seeking individuals with prodromal risk syndromes. 
Further cross-sectional and longitudinal research comparing clinical and 
community samples will be necessary to address this question.
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Hallucinations and delusions, while classically known as symptoms of 
psychosis, are common in a wide range of non-psychotic psychiatric 
disorders in young people. These symptoms appear to become increasingly 
associated with diagnosable psychopathology with age. Psychotic symptoms 
demonstrated a particularly strong relationship with more severe 
psychopathology, indexing a large increase in risk for comorbid diagnoses. 
The immediate clinical implications of these findings are that (i) psychotic 
symptoms, which are to a large extent seen as an ‘adult psychiatry’ issue, 
are in fact very prevalent in childhood and adolescence and should be 
carefully assessed in child and adolescent psychiatric clinics, and (ii) when 
psychotic symptoms are present, they index risk for more severe 
psychopathology, necessitating a consideration of the possibility of multiple 
diagnoses and, following from this, the potential importance of multiple 
therapeutic targets or approaches. For researchers, these findings highlight 
psychotic symptoms as a complex novel aspect in the study of the aetiology 
of severe mental illness, of which schizophrenia is only one.
The results of the studies reported here also demonstrate that psychotic 
symptoms index greatly increased risk for suicidal behaviour, both in 
adolescents in the general population and in adolescents with diagnosable 
psychiatric disorder, and that the presence of psychotic symptoms greatly 
increases the risk for more severe suicidal behaviour among adolescents
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with suicidal ideation and with depressive and behavioural disorders. Both 
interview studies showed that, when directly questioned, the majority of 
adolescents with suicidal plans and acts reported psychotic symptoms, in 
particular auditory hallucinations. The immediate clinical relevance of these 
findings is that patients presenting at risk for suicidal behaviour should 
receive a thorough assessment of psychotic symptoms, and not just a 
screening to rule out psychotic disorder. Since approximately half of patients 
who complete suicide have contact with primary care providers in the month 
preceding their death (Luoma e t  a l. ,  2002), it is important that clinicians are 
aware of the significance of psychotic symptoms in non-psychotic patients in 
terms of risk for suicidal behaviour. Among patients presenting with mood or 
behavioural disorders or with suicidal ideation, these results suggest that 
disclosure of psychotic symptoms, particularly hallucinations (regardless of 
their phenomenological content), indicates a greatly increased risk for more 
severe suicidal behaviour.
In terms of neurocognitive function, adolescents with psychotic symptoms 
demonstrated impairments on processing speed tasks and in non-verbal 
working memory. This group likely demonstrates some of the earliest 
cognitive impairments associated with a psychosis phenotype. Our findings 
support the idea that impairment in processing speed and, to a lesser extent, 
working memory, is at the core of neurocognitive dysfunction in psychosis. 
This adds to the evidence that a systems-based dysfunction may be the core
108
cognitive feature of psychosis, as opposed to cognitive features that suggest 
that the pathology emerges from localised or region-specific deficits.
Up to 8% of 11 to 13 year olds met formal criteria for a prodromal risk 
syndrome (compared to 23% who reported psychotic symptoms). 
Adolescents with prodromal risk syndromes demonstrated poorer global 
functioning and high rates of non-psychotic psychopathology, consistent with 
findings on clinically presenting risk syndrome patients. The long term 
outcomes for these ‘community risk syndromes’ has yet to be determined 
and will require further research. However, the decline in rates of conversion 
to psychosis at risk syndrome clinics over the past number of years 
highlights the fact that, even in clinically presenting individuals, outcomes are 
not clear cut (Addington e t  a l. , 2011, Yung e t  a i ,  2007b). Follow up research 
will be necessary to determine the degree of risk for clinical psychosis 
associated with prodromal risk syndromes in the community.
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A p p e n d i x  A :  T h e  A d o l e s c e n t  P s y c h o t i c  S y m p t o m  S c r e e n e r  
( A P S S )
Please tick one box for each question
No,
Never Maybe
Yes,
definitely
Some people believe that their thoughts can be read by another person. Have 
other people ever read your mind? □ □ □
Have you ever had messages sent just to you through TV or radio? □ □ □
Have you ever felt that you were under the control of some special power? □ □ □
Have you ever heard voices or sounds that 110 one else can hear? □ □ □
Have you ever seen things that other people could not see? □ □ □
Have vou ever felt that vou have extra-SDecial Dowers? □ □ □
Have you ever thought that people are following you or spying on you? □ □ □
Thank you very much for your help!
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A p p e n d i x  B :  S t r e n g t h s  a n d  D i f f i c u l t i e s  Q u e s t i o n n a i r e
Please tick one box fo r each question
Maybe * . ’, Never definitely
I try to be nice to other people. I care about their feelings □ □ □
I am restless, I cannot stay still for long □ □ □
I get a lot of headaches, stomach-aches or sickness □ □ □
I usually share with others, for example CD’s, games, food □ □ □
I get very angry and often lose my temper □ □ □
I would rather be alone than with people of my age □ □ □
I usually do as 1 am told □ □ □
I worry a lot □ □ □
I am helpful if someone is hurt, upset or feeling ill □ □ □
I am constantly fidgeting or squirming □ □ □
I have one good friend or more □ □ □
I fight a lot, I can make other people do what I want □ □ □
I am often unhappy, depressed or tearful □ □ □
Other people my age generally like me □ □ □
I am easily distracted, I find it difficult to concentrate □ □ □
I am nervous in new situations. I easily lose confidence □ □ □
I am kind to younger children □ □ □
I am often accused of lying or cheating □ □ □
Other children or young people pick on me or bully me □ □ □
I often offer to help others (parents, teachers, children) □ □ □
I think before I do things □ □ □
I take things that are not mine from home, school or elsewhere □ □ □
I get along better with adults than with people my own age □ □ □
I have many fears, I am easily scared □ □ □
I finish the work I’m doing. My attention is good □ □ □
Thank you very much for your help!
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i n  t h e  A B D  s t u d y
Appendix C: Clinical classification of psychotic symptoms
Essentially a strong psychotic symptom refers to experiencing hallucinations and/or 
delusions. Not all such phenomena are o f equal clinical significance, however. The 
following characteristics help to separate hallucinations and delusions o f potential 
clinical significance from hallucinations and delusions that are o f limited or no 
clinical significance.
Hallucinations:
Auditory hallucinations may involve voices or other sounds. A formed hallucination 
involves hearing one or more voices saying at least one word and is classed as a 
strong psychotic symptom in general (see notes below for notable exceptions). 
Common formed auditory hallucinations, classed as strong psychotic symptoms, 
include
• Voice commenting on behaviour
• Voice giving commands
• Voices conversing
Unformed auditory hallucinations may involve whispering voices, voices at normal 
volume or shouting voices where the words cannot clearly be distinguished by the 
individual. These are classed as strong psychotic symptoms in general
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Auditory hallucinations may also include non-vocal sounds, such as music playing 
or animal noises but these are generally classed as weak psychotic symptoms. E.g., 
hearing music playing for a short period o f time when none is playing would be 
classed a weak psychotic symptom unless it is distressing or disorganizing, when it 
would be classed a strong psychotic symptom. Experiences that are very common 
such as occasionally hearing footsteps or knocking, are not classed as psychotic 
symptoms unless these experiences are associated with delusional ideation.
Visual hallucinations are classically thought to be associated with organic pathology 
but are not uncommon types o f psychotic symptoms in the general population. They 
often occur in individuals who also experience auditory hallucinations. Common 
visual hallucinations, which are rated as strong psychotic symptoms, include seeing
• People
• Faces
• Ghosts
• Aliens
Tactile hallucinations are common but most could be considered trivial and would 
not be classed as psychotic symptoms. For example, most people report experiencing 
their mobile telephone vibrating when it had not really done so or occasionally 
feeling something brush lightly against their skin when nothing was there. These 
experiences would not be classed as psychotic symptoms unless they involved 
delusional attributions (e.g., believing it was a ghost that was brushing against them). 
Isolated tactile hallucinations that would be classed as psychotic symptoms are 
unusual but may occur ocassionally (e.g., recurring feeling o f  forceful physical touch
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when nobody was there), but would generally be rated as weak psychotic symptoms 
in the absence o f  delusional attributions.
Olfactory and gustatory hallucinations are not uncommon but are rarely significant 
enough to warrant classification as a strong psychotic symptom. Occasional 
experiences o f smells or tastes which are not distressing are not classed as psychotic 
symptoms. Some individuals may report recurrent experiences o f clearly smelling a 
particular food (often one the individual desires) which they have found odd; this 
type o f experience would be rated as a weak psychotic symptom.
Note on rating formed hallucinations
Exceptions, which are not considered psychotic symptoms, include experiences that 
are very common if  not universal, including the experience of hearing one’s own 
name when no one has called it, unless such experiences are associated with 
delusional beliefs (e.g., a ghost is calling my name).
Brief experiences o f gedankenlautwerden (the experience o f hearing one’s own 
thoughts aloud even though the individual did not speak them) are common in 
childhood and early adolescence and are classed as weak psychotic symptoms as 
long as they are brief in duration (a few words or one sentence), are not associated 
with delusional ideation and are not experienced as significantly distressing or 
disorganising. Frequency o f gedankenlautwerden varies, but does not in-and-of-itself 
impact on rating.
Note on illusions
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Common illusions such as occasionally hearing the doorbell or the telephone while 
the TV or radio are playing, or seeing a coat from the comer o f one’s eye and briefly 
believing it to be a person, are not classed as psychotic symptoms. However, more 
elaborate illusions, for example thinking that a face in a picture or poster had been 
moving, would be classed as a weak psychotic symptom.
Note on hypnagogic and hypnopompic hallucinations
Hypnagogic and hypnopompic hallucinations are generally not classed as psychotic 
symptoms. However, it is important to distinguish between
hypnopompic/hypnagogic and simply being in bed -  if  the individual is not actually 
in the process o f waking up or falling asleep then the hallucination should not be 
dismissed as hypnopompic/hypnagogic; it is often at night time that individuals are 
alone and hallucinatory experiences may be more likely to occur and these 
experiences are classed the same as any other psychotic symptom.
Hallucinations that occur only when the individual is tired (but not falling asleep or 
awakening) and are brief in duration would be classed as weak psychotic symptoms 
(e.g., a vague but identifiable image o f a person moving past the doorway). 
Prolonged hallucinations would be classed as strong psychotic symptoms even if  the 
individual is tired.
Note on hallucinations versus pseudohallucinations
Insight into the hallucination (a ‘pseudohallucination’) does not preclude it from 
being classed as a strong (or weak) psychotic symptom.
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Very brief hallucinations that occur only when daydreaming would generally be 
classed as weak psychotic symptoms.
Note on illness and intoxication
Hallucinations that occur as the result o f an organic illness (e.g., a fever) are not 
classed as psychotic symptoms. Whether or not to include psychotic symptoms that 
are associated with drug use is unclear; we would generally include psychotic 
symptoms that occur other than during acute intoxication.
Delusions:
Significant delusions most commonly occur in individuals who also experience 
hallucinations and often relate to the content o f the hallucination, though they may 
also occur in individuals with no hallucinations. The following are experiences that 
are commonly encountered.
• A vague feeling o f unease associated with the occasional feeling that someone 
may be watching the individual would be classed as a weak psychotic symptom. 
More frequent or more concrete ideas about being watched, such as being able to 
suggest a certain person or organisation as being responsible or the belief that 
cameras have been set up to watch the individual, would be classed as a strong 
psychotic symptom.
• Recurrent, unfounded or very exaggerated ideas that others (generally more than 
one person or group) are saying negative things about the individual would be 
classed as a strong psychotic symptom. Care must be taken, however, to
Note on hallucinations and daydreaming
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distinguish paranoia from self-consciousness (e.g., about clothes or physical 
appearance), which is not classed as a psychotic symptom.
• Bizarre attributions for experiences (e.g., the belief that ghosts/deceased 
relatives/aliens are the cause o f the experience) are not uncommon. A belief that 
ghosts/spirits can influence events is in-keeping with many cultures/subcultures 
and would not be considered a psychotic symptom. However, the belief that 
ghosts are directly communicating with the individual in question (for example, 
the ghost o f a dead relative) would be considered a strong psychotic symptom.
• Subcultural beliefs about that the world may be coming to an end are not 
uncommon among young people and are often in-keeping with ideas from books 
or film. These would generally be classed as weak psychotic symptoms unless 
they are o f a psychotic level o f intensity (unshakable conviction), when they 
would be classed as strong psychotic symptoms.
• A belief that one can read minds or that one’s mind has been read is usually 
somewhat in-keeping with subcultural beliefs about psychics and is generally 
classed as a weak psychotic symptom at most. In some circumstances, however, 
it would be classed as a strong psychotic symptom, for example, if  it was 
associated with paranoia, such as the individual believed that others had singled 
out him/her and were aiming to read their mind for a particular (usually 
nefarious) reason.
• A vague unsubstantiated but persistent feeling that something strange is going on 
or that the individual feels he or she might be ‘going crazy’ despite no specific or 
concrete examples o f hallucinations or delusions would be classed as a weak 
psychotic symptom.
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•  Note: magical thinking, such as a belief that one had predicted the future, is very 
common and is generally classed as a weak psychotic symptom at most, unless, 
for example, it is distressing or disorganising.
Note on severity o f hallucinations and delusions
The significance o f thè severity o f the hallucination or delusion is unclear at present 
However, there are a range o f  severities in the experiences that can be considered 
strong psychotic symptoms.
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A p p e n d i x  D :  C l i n i c a l  c l a s s i f i c a t i o n  o f  p r o d r o m a l  r i s k  
s y n d r o m e s :  C r i t e r i a  o f  t h e  S c a l e  o f  P r o d r o m a l  S y n d r o m e s
The Scale o f Prodromal Syndromes (SOPS) criteria facilitate diagnosis o f three ‘risk 
syndromes’ for psychosis: (i) attenuated positive symptoms prodromal syndrome 
(APSP), (ii) brief intermittent psychotic symptoms prodromal syndrome (BIPS), and 
(iii) genetic risk and deterioration prodromal syndrome (GRD). These diagnoses are 
operationalized based principally on positive symptoms assessed in clinical 
interview. The SIPS assesses five subtypes o f  positive symptoms on five scales: PI 
to P5. P I: Unusual thought content/delusional ideas; P2: Suspiciousness/Persecutory 
ideas; P3: Grandiose ideas; P4: Perceptual abnormalities/hallucinations; P5: 
Disorganized communication. Each o f these scales can be scored from 0 to 6 for 
each participant as follows:
0 = Absent
1 = Questionably present
2 = Mild
3 = Moderate
4 = Moderately severe
5 = Severe but not psychotic
6 = Severe and psychotic
Questions about psychotic symptomatology from the SOPS that were not adequately 
assessed by the K-SADS were added to the instrument for the purposes o f  assessing 
prodromal syndromes in the current study.
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Each o f the scales PI to P5 includes a severity scale that guides the clinical rating.
P I: Unusual thought content/Delusional ideas Severity scale
• 0 = Absent
• 1 = Questionably present
-  ‘Mind tricks’ that are puzzling. Sense that something is different.
• 2 = Mild
-  Over interested in fantasy life. Unusually valued ideas/beliefs. Some 
superstitions beyond what might be expected by the average person 
within cultural norms.
• 3 = Moderate
-  Unanticipated mental events/non-persecutory ideas o f reference/mind 
tricks/magical thinking that are not easily dismissed and may be 
irritating and worrisome. A sense that these experiences or 
compelling new beliefs are becoming meaningful because they will 
not go away.
• 4 = Moderately severe
-  Notion that experiences may be coming from outside the self or that 
ideas/beliefs may be real, but scepticism remains intact. Does not 
usually affect functioning.
• 5 = Severe but not psychotic
-  Belief in reality o f ‘mind tricks’/mental events/external 
control/magical thinking is compelling but doubt can be induced by 
contrary evidence and other’s opinions. May affect functioning.
• 6 = Severe and psychotic
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— Delusional conviction (with no doubt) at least intermittently. Usually 
interferes with thinking, social relations, or behaviour.
P2: Suspiciousness/Persecutory ideas Severity scale
• 0 = Absent
• 1 = Questionably present
-  Wariness.
• 2 = Mild
-  Doubts about safety. Hypervigilance without clear source o f danger.
3 = Moderate
-  Notions that people are hostile, untrustworthy, and/or harbour ill will 
easily. Sense that hypervigilance may be necessary. Mistrustful. 
Recurrent (yet unfounded or exaggerated at times) sense that people 
are thinking or saying negative things about person. May appear 
mistrustful with interviewer.
4 = Moderately severe
-  Clear or compelling thoughts o f being watched or singled out. Sense 
that people intend to harm. Beliefs easily dismissed. Presentation may 
appear guarded. Reluctant or irritable in response to questioning.
• 5 = Severe but not psychotic
-  Loosely organized beliefs about danger or hostile intention. 
Scepticism and perspective can be elicited with non-confirming 
evidence or opinion. Behaviour is affected to some degree. Guarded 
presentation may interfere with ability to gather information in the 
interview.
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• 6 = Severe and psychotic
-  Delusional paranoid conviction (with no doubt) at least intermittently. 
Likely to affect functioning.
P3: Grandiose ideas Severity scale
• 0 = Absent
1 = Questionably present
-  Private thoughts o f being generally superior in intellect or talent.
• 2 = Mild
-  Thoughts o f being particularly talented, highly understanding, or 
gifted in one or more areas. Thoughts kept mostly private.
• 3 = Moderate
-  Notions o f being unusually gifted, powerful, or special. May be 
expansive. Promotes significantly unrealistic plans, but easily 
reoriented.
• 4 = Moderately severe
-  Loosely organized beliefs o f power, wealth, talent or abilities. 
Unrealistic goals that may affect plans and functioning.
5 = Severe but not psychotic
-  Persistent beliefs o f having superior intellect, attractiveness, power or 
fame. Scepticism about belief can be elicited. Often influences 
behaviour or actions.
• 6 = Severe and psychotic
-  Delusions o f grandiosity with conviction (no doubt) at least 
intermittently. Influences behaviour and beliefs.
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• 0 = Absent
• 1 = Questionably present
-  Minor but noticeable perceptual sensitivity (e.g., heightened, dulled, 
distorted etc.).
• 2 = Mild
-  Unexpected, unformed perceptual experiences/changes that are 
puzzling but are not considered to be significant.
• 3 = Moderate
-  Repeated unformed images (e.g., shadows, trails, sounds etc.), 
illusions or persistent perceptual distortions that may be worrisome or 
experienced as unusual.
• 4 = Moderately severe
-  Recurrent illusions or momentary hallucinations that are recognized 
as not real yet can be frightening or captivating, and may affect 
behaviour slightly. Not sure o f source o f experiences.
• 5 = Severe but not psychotic
-  Hallucinations that occasionally affect thinking or behaviour that are 
experienced as possibly external to self or possibly real. Scepticism 
can be induced.
• 6 = Severe and psychotic
-  Recurrent hallucinations perceived as real and distinct from the 
person’s thoughts. Clearly influence thinking, feeling, and/or 
behaviour. Scepticism cannot be induced.
P 4 : P e rc e p tu a l a b n o rm a lit ie s / H a llu c in a t io n s  S e v e r it y  sc a le
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• 0 = Absent
1 = Questionably present
-  Some words or phrases that don’t make sense.
• 2 = Mild
-  Occasionally vague, confused, muddled, inconsistent 
communications. May go off track briefly.
• 3 = Moderate
-  Occasional incorrect words, irrelevant topics. Frequently going off 
track but responds easily to clarifying questions. Stereotyped or over­
elaborate speech.
• 4 = Moderately severe
-  Speech is clearly circumstantial (i.e., eventually getting to the point). 
Some difficulty in directing sentences toward a goal. Person is able to 
be redirected through questioning and structure.
5 = Severe but not psychotic
-  Communications are tangential (i.e., never getting to the point). Some 
loosening o f associations under pressure. Can respond accurately to 
brief questions.
• 6 = Severe and psychotic
-  Communication is loose or irrelevant and unintelligible when under 
minimal pressure or when the content o f the communication is 
complex. Not responsive to structuring o f the conversation.
P 5 : D is o r g a n iz e d  c o m m u n ic a t io n  S e v e r ity  sc a le
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A diagnosis o f  APSP is operationalized where (i) at least one o f the SOPS PI to P5 
scales is scored three (moderate), four (moderately severe) or five (severe but not 
psychotic), (ii) symptom(s) have begun, or worsened by one or more scale points, 
within the past 12 months and (iii) symptom(s) have occurred at an average 
frequency o f at least once per week in the past month.
A diagnosis o f BIPS is operationalized where (i) the SOPS PI to P5 scales (which 
relate to positive psychotic symptoms) rate a six (that is, psychotic), (ii) the 
symptom(s) have reached a psychotic level o f intensity within the past three months 
and (iii) the symptom(s) have been present for at least several minutes per day at a 
frequency o f at least once per month.
GRD is diagnosed where there has been a drop o f at least 30% in the Global 
Assessment o f Functioning score over the past month as compared to 12 months ago 
and one or both o f the following criteria are also fulfilled: (i) the individual meets 
criteria for current schizotypal personality disorder and/or (ii) the individual has a 
first degree relative with a psychotic disorder. In reality, given the complex issues 
around diagnosing young people (aged 11-13 years) with a personality disorder, a 
diagnosis o f GRD could only be given in the present study if, in addition to the 
stipulated functional decline, the individual had a first degree relative with a 
psychotic disorder.
137
A p p e n d i x  E :  C l i n i c a l  A s s e s s m e n t  o f  A t  R i s k  M e n t a l  
S t a t e s  ( C A A R M S )  c r i t e r i a
Prodromal syndrome diagnostic categories include (i) vulnerability group, (ii) 
attenuated psychosis group and (iii) brief limited intermittent psychotic symptoms 
(BLIPS group)
1. Vulnerability Group criteria
la) Family history o f  psychosis in a first degree relative or schizotypal personality
disorder in the identified patient
Plus
lb) 30% drop in social/occupational functioning (measured on the Social and 
Occupational Functioning Assessment Scale -  SOFAS) compared to premorbid 
level, sustained for a month, occurred within past 12 months or a SOFAS score o f 50 
or less for past 12 months or longer
2. Attenuated Psychosis Group criteria
2a) Psychotic symptoms o f subthreshold intensity, specifically a global rating scale 
score o f 3-5 on Unusual Thought Content subscale, 3-5 on Non-Bizarre Ideas 
subscale, 3-4 on Perceptual Abnormalities subscale and/or 4-5 on Disorganised 
Speech subscales o f the CAARMS 
Plus
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2b) Frequency Scale Score o f  3-6 on Unusual Thought Content, Non-Bizarre Ideas, 
Perceptual Abnormalities and/or Disorganised Speech subscales o f  the CAARMS for 
at least a week
2c) Subthreshold frequency: Global Rating Scale score o f 6 on Unusual Thought 
Content, 6 on Non-Bizarre Ideas, 5-6 on Perceptual Abnormalities and/or 6 on 
Disorganised Speech subscales o f  the CAARMS 
Plus
2d) Frequency scale score o f 3 on Unusual Thought Content, Non-Bizarre Ideas, 
Perceptual Abnormalities and/or Disorganised Speech subscales o f  CAARMS 
Plus (for both categories)
2e) Symptoms present in past year 
Plus (for both categories)
2f) 30% drop in SOFAS score from premorbid level, sustained for a whole month, 
occurred within past 12 months or SOFAS score o f 50 or less for past 12 months or 
longer
3. BLIPS Group criteria
3)a Global Rating Scale score o f 6 on Unusual Thought Content subscale, 6 on Non- 
Bizarre Ideas, 5 or 6 on Perceptual Abnormalities subscale and/or 6 on Disorganised 
Speech subscales o f the CAARMS 
Plus
3b) Frequency Scale score o f 4-6 on Unusual Thought Content, Non-Bizarre Ideas,
Perceptual Abnormalities and/or Disorganised Speech subscales
Plus
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spontaneously remit on every occasion
Plus
3d) Symptoms occurred during last year 
Plus
3e) 30% drop in SOFAS score from premorbid level, sustained for a month, occurred 
within past 12 months or SOFAS score o f  50 or less for past 12 months or longer
Note: in the current study the social/occupational functioning measure was the 
Children’s Global Assessment Scale and not Social and Occupational Functioning 
Assessment Scale. The criterion o f a 30% decline in social/occupational functioning 
was added to the most recent edition o f the CAARMS but was not a criterion for 
prodromal syndromes in previously published research. We report prevalences for 
CAARMS prodromal syndromes (i) without and (ii) with this new criterion.
3 c ) E a c h  e p iso d e  o f  s y m p to m s is  p re se n t fo r  le ss  than  o ne w e e k  an d  sy m p to m s
I
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